trial_id,title,condition,drug,phase,status
NCT34810,Phase 1 Study of IL-6 Inhibitor in Alzheimer's,Asthma,Metformin,Phase 1,Withdrawn
NCT85467,Phase 2 Study of Metformin in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 2,Withdrawn
NCT54300,Phase 2 Study of mRNA-101 in Cancer,Cancer,mRNA-101,Phase 2,Withdrawn
NCT17181,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,IL-6 Inhibitor,Phase 3,Recruiting
NCT11581,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,BACE Inhibitor,Phase 3,Withdrawn
NCT97525,Phase 3 Study of Monoclonal Antibody in Alzheimer's,Asthma,BACE Inhibitor,Phase 1,Withdrawn
NCT49863,Phase 1 Study of mRNA-101 in Cancer,Cancer,Monoclonal Antibody,Phase 1,Terminated
NCT99533,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Type 2 Diabetes,BACE Inhibitor,Phase 3,Recruiting
NCT92821,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Asthma,IL-6 Inhibitor,Phase 1,Recruiting
NCT72461,Phase 3 Study of Metformin in Alzheimer's,Alzheimer's,mRNA-101,Phase 2,Recruiting
NCT21222,Phase 1 Study of Monoclonal Antibody in Alzheimer's,Cancer,Monoclonal Antibody,Phase 3,Recruiting
NCT71842,Phase 2 Study of mRNA-101 in Rheumatoid Arthritis,Asthma,BACE Inhibitor,Phase 1,Recruiting
NCT55359,Phase 1 Study of Metformin in Type 2 Diabetes,Alzheimer's,mRNA-101,Phase 2,Recruiting
NCT17881,Phase 1 Study of IL-6 Inhibitor in Asthma,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Recruiting
NCT23568,Phase 2 Study of mRNA-101 in Alzheimer's,Cancer,Metformin,Phase 1,Completed
NCT77758,Phase 1 Study of BACE Inhibitor in Alzheimer's,Rheumatoid Arthritis,Metformin,Phase 3,Withdrawn
NCT56192,Phase 1 Study of Metformin in Cancer,Rheumatoid Arthritis,mRNA-101,Phase 3,Withdrawn
NCT53239,Phase 2 Study of Metformin in Alzheimer's,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Recruiting
NCT97507,Phase 2 Study of mRNA-101 in Asthma,Type 2 Diabetes,mRNA-101,Phase 2,Terminated
NCT28618,Phase 1 Study of BACE Inhibitor in Cancer,Cancer,IL-6 Inhibitor,Phase 1,Terminated
NCT41617,Phase 1 Study of mRNA-101 in Cancer,Alzheimer's,BACE Inhibitor,Phase 1,Completed
NCT96460,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Type 2 Diabetes,BACE Inhibitor,Phase 3,Completed
NCT18548,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Withdrawn
NCT53528,Phase 2 Study of mRNA-101 in Asthma,Asthma,BACE Inhibitor,Phase 3,Withdrawn
NCT68468,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Completed
NCT54605,Phase 2 Study of BACE Inhibitor in Asthma,Alzheimer's,Monoclonal Antibody,Phase 1,Terminated
NCT89501,Phase 1 Study of IL-6 Inhibitor in Alzheimer's,Alzheimer's,mRNA-101,Phase 1,Terminated
NCT57714,Phase 3 Study of BACE Inhibitor in Alzheimer's,Cancer,Monoclonal Antibody,Phase 2,Completed
NCT55421,Phase 3 Study of mRNA-101 in Alzheimer's,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Recruiting
NCT70284,Phase 1 Study of Metformin in Alzheimer's,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Terminated
NCT48786,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Type 2 Diabetes,BACE Inhibitor,Phase 3,Withdrawn
NCT37655,Phase 1 Study of Metformin in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Completed
NCT20987,Phase 1 Study of Monoclonal Antibody in Asthma,Alzheimer's,Metformin,Phase 2,Completed
NCT77563,Phase 3 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,BACE Inhibitor,Phase 2,Completed
NCT98402,Phase 3 Study of IL-6 Inhibitor in Asthma,Alzheimer's,Metformin,Phase 2,Withdrawn
NCT36381,Phase 2 Study of Metformin in Asthma,Rheumatoid Arthritis,mRNA-101,Phase 3,Terminated
NCT58969,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Cancer,Metformin,Phase 2,Terminated
NCT73370,Phase 2 Study of mRNA-101 in Asthma,Alzheimer's,mRNA-101,Phase 1,Recruiting
NCT33284,Phase 3 Study of BACE Inhibitor in Cancer,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Recruiting
NCT86127,Phase 1 Study of BACE Inhibitor in Alzheimer's,Rheumatoid Arthritis,Monoclonal Antibody,Phase 2,Completed
NCT97374,Phase 1 Study of IL-6 Inhibitor in Cancer,Alzheimer's,BACE Inhibitor,Phase 2,Terminated
NCT69669,Phase 1 Study of Monoclonal Antibody in Rheumatoid Arthritis,Asthma,Metformin,Phase 3,Terminated
NCT56557,Phase 1 Study of mRNA-101 in Asthma,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 2,Recruiting
NCT87499,Phase 2 Study of mRNA-101 in Asthma,Asthma,BACE Inhibitor,Phase 1,Withdrawn
NCT68307,Phase 2 Study of IL-6 Inhibitor in Asthma,Alzheimer's,BACE Inhibitor,Phase 1,Recruiting
NCT74570,Phase 1 Study of Monoclonal Antibody in Asthma,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Completed
NCT77020,Phase 1 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,Monoclonal Antibody,Phase 2,Recruiting
NCT95906,Phase 1 Study of IL-6 Inhibitor in Cancer,Alzheimer's,IL-6 Inhibitor,Phase 2,Recruiting
NCT99510,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Asthma,BACE Inhibitor,Phase 2,Recruiting
NCT73826,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Asthma,IL-6 Inhibitor,Phase 1,Terminated
NCT32399,Phase 3 Study of Metformin in Type 2 Diabetes,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Completed
NCT75230,Phase 2 Study of Monoclonal Antibody in Asthma,Alzheimer's,Monoclonal Antibody,Phase 1,Withdrawn
NCT62112,Phase 2 Study of Metformin in Type 2 Diabetes,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Terminated
NCT48644,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Rheumatoid Arthritis,Monoclonal Antibody,Phase 2,Withdrawn
NCT17265,Phase 1 Study of BACE Inhibitor in Cancer,Asthma,Monoclonal Antibody,Phase 3,Recruiting
NCT60581,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Asthma,Monoclonal Antibody,Phase 2,Completed
NCT75930,Phase 2 Study of mRNA-101 in Rheumatoid Arthritis,Rheumatoid Arthritis,Metformin,Phase 2,Recruiting
NCT50466,Phase 2 Study of mRNA-101 in Asthma,Cancer,BACE Inhibitor,Phase 1,Completed
NCT86459,Phase 3 Study of mRNA-101 in Rheumatoid Arthritis,Type 2 Diabetes,mRNA-101,Phase 2,Terminated
NCT50320,Phase 1 Study of BACE Inhibitor in Asthma,Asthma,Monoclonal Antibody,Phase 2,Completed
NCT95528,Phase 3 Study of BACE Inhibitor in Asthma,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Recruiting
NCT16029,Phase 1 Study of Metformin in Cancer,Asthma,mRNA-101,Phase 1,Recruiting
NCT62981,Phase 2 Study of IL-6 Inhibitor in Asthma,Alzheimer's,BACE Inhibitor,Phase 3,Terminated
NCT87873,Phase 3 Study of Metformin in Alzheimer's,Alzheimer's,BACE Inhibitor,Phase 3,Withdrawn
NCT18223,Phase 2 Study of Metformin in Type 2 Diabetes,Asthma,IL-6 Inhibitor,Phase 1,Withdrawn
NCT40979,Phase 3 Study of Metformin in Type 2 Diabetes,Alzheimer's,Monoclonal Antibody,Phase 1,Recruiting
NCT48531,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Completed
NCT72970,Phase 2 Study of IL-6 Inhibitor in Asthma,Alzheimer's,BACE Inhibitor,Phase 2,Recruiting
NCT61205,Phase 2 Study of Metformin in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 2,Withdrawn
NCT55555,Phase 1 Study of mRNA-101 in Alzheimer's,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Completed
NCT31923,Phase 3 Study of Metformin in Asthma,Alzheimer's,Metformin,Phase 3,Withdrawn
NCT40903,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Completed
NCT81960,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Recruiting
NCT18766,Phase 3 Study of mRNA-101 in Rheumatoid Arthritis,Alzheimer's,BACE Inhibitor,Phase 3,Recruiting
NCT96195,Phase 1 Study of IL-6 Inhibitor in Alzheimer's,Rheumatoid Arthritis,mRNA-101,Phase 2,Completed
NCT80752,Phase 1 Study of mRNA-101 in Type 2 Diabetes,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Recruiting
NCT10685,Phase 2 Study of Metformin in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 1,Recruiting
NCT68422,Phase 1 Study of Monoclonal Antibody in Asthma,Type 2 Diabetes,BACE Inhibitor,Phase 3,Completed
NCT93196,Phase 1 Study of BACE Inhibitor in Alzheimer's,Alzheimer's,mRNA-101,Phase 2,Completed
NCT57826,Phase 2 Study of Metformin in Rheumatoid Arthritis,Alzheimer's,IL-6 Inhibitor,Phase 3,Terminated
NCT42226,Phase 2 Study of Metformin in Alzheimer's,Cancer,mRNA-101,Phase 2,Withdrawn
NCT37842,Phase 1 Study of Metformin in Cancer,Alzheimer's,Monoclonal Antibody,Phase 2,Recruiting
NCT98887,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,Metformin,Phase 3,Completed
NCT28645,Phase 2 Study of BACE Inhibitor in Asthma,Asthma,mRNA-101,Phase 1,Withdrawn
NCT32859,Phase 1 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 2,Terminated
NCT20144,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,IL-6 Inhibitor,Phase 3,Withdrawn
NCT37761,Phase 1 Study of BACE Inhibitor in Cancer,Cancer,Monoclonal Antibody,Phase 3,Recruiting
NCT17905,Phase 2 Study of Monoclonal Antibody in Asthma,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Recruiting
NCT26952,Phase 1 Study of Monoclonal Antibody in Cancer,Alzheimer's,BACE Inhibitor,Phase 3,Recruiting
NCT69406,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Alzheimer's,Monoclonal Antibody,Phase 2,Recruiting
NCT64712,Phase 3 Study of mRNA-101 in Rheumatoid Arthritis,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Recruiting
NCT16171,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Terminated
NCT30179,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Asthma,Metformin,Phase 2,Terminated
NCT69237,Phase 1 Study of IL-6 Inhibitor in Asthma,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Terminated
NCT90771,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 2,Terminated
NCT22011,Phase 2 Study of Monoclonal Antibody in Cancer,Rheumatoid Arthritis,mRNA-101,Phase 1,Terminated
NCT71442,Phase 2 Study of mRNA-101 in Asthma,Type 2 Diabetes,mRNA-101,Phase 1,Recruiting
NCT45205,Phase 2 Study of IL-6 Inhibitor in Asthma,Rheumatoid Arthritis,mRNA-101,Phase 3,Completed
NCT42438,Phase 1 Study of Metformin in Asthma,Asthma,IL-6 Inhibitor,Phase 1,Terminated
NCT27314,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Asthma,Metformin,Phase 2,Completed
NCT25012,Phase 1 Study of IL-6 Inhibitor in Alzheimer's,Asthma,Metformin,Phase 1,Withdrawn
NCT38682,Phase 2 Study of mRNA-101 in Rheumatoid Arthritis,Cancer,Metformin,Phase 1,Recruiting
NCT90639,Phase 1 Study of IL-6 Inhibitor in Cancer,Type 2 Diabetes,mRNA-101,Phase 1,Terminated
NCT80853,Phase 2 Study of Metformin in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Withdrawn
NCT90374,Phase 1 Study of Monoclonal Antibody in Alzheimer's,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 2,Recruiting
NCT50998,Phase 2 Study of Metformin in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 1,Recruiting
NCT21656,Phase 2 Study of Metformin in Alzheimer's,Asthma,Metformin,Phase 1,Terminated
NCT78575,Phase 3 Study of Monoclonal Antibody in Alzheimer's,Asthma,IL-6 Inhibitor,Phase 3,Terminated
NCT77642,Phase 3 Study of Metformin in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 3,Terminated
NCT68339,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Type 2 Diabetes,Metformin,Phase 1,Completed
NCT14014,Phase 1 Study of mRNA-101 in Alzheimer's,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Withdrawn
NCT10159,Phase 2 Study of mRNA-101 in Cancer,Asthma,mRNA-101,Phase 1,Withdrawn
NCT58783,Phase 2 Study of BACE Inhibitor in Alzheimer's,Cancer,Monoclonal Antibody,Phase 2,Terminated
NCT42520,Phase 3 Study of Monoclonal Antibody in Asthma,Alzheimer's,Monoclonal Antibody,Phase 1,Terminated
NCT42314,Phase 3 Study of Monoclonal Antibody in Cancer,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Completed
NCT70416,Phase 3 Study of IL-6 Inhibitor in Alzheimer's,Alzheimer's,BACE Inhibitor,Phase 1,Withdrawn
NCT97803,Phase 2 Study of Monoclonal Antibody in Asthma,Asthma,BACE Inhibitor,Phase 3,Recruiting
NCT85922,Phase 1 Study of BACE Inhibitor in Asthma,Type 2 Diabetes,BACE Inhibitor,Phase 3,Withdrawn
NCT75105,Phase 1 Study of IL-6 Inhibitor in Alzheimer's,Cancer,BACE Inhibitor,Phase 2,Recruiting
NCT32207,Phase 2 Study of Metformin in Rheumatoid Arthritis,Type 2 Diabetes,mRNA-101,Phase 1,Completed
NCT35621,Phase 3 Study of BACE Inhibitor in Alzheimer's,Cancer,mRNA-101,Phase 1,Withdrawn
NCT88764,Phase 2 Study of mRNA-101 in Asthma,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Terminated
NCT15199,Phase 1 Study of BACE Inhibitor in Rheumatoid Arthritis,Type 2 Diabetes,Metformin,Phase 1,Withdrawn
NCT30168,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Rheumatoid Arthritis,Metformin,Phase 1,Withdrawn
NCT56403,Phase 2 Study of Metformin in Asthma,Asthma,mRNA-101,Phase 1,Recruiting
NCT75420,Phase 2 Study of mRNA-101 in Rheumatoid Arthritis,Asthma,IL-6 Inhibitor,Phase 2,Withdrawn
NCT42592,Phase 1 Study of BACE Inhibitor in Cancer,Alzheimer's,mRNA-101,Phase 1,Withdrawn
NCT11433,Phase 1 Study of Metformin in Alzheimer's,Cancer,Monoclonal Antibody,Phase 3,Recruiting
NCT54912,Phase 1 Study of IL-6 Inhibitor in Asthma,Cancer,BACE Inhibitor,Phase 1,Recruiting
NCT22462,Phase 3 Study of IL-6 Inhibitor in Asthma,Cancer,IL-6 Inhibitor,Phase 2,Completed
NCT26689,Phase 3 Study of BACE Inhibitor in Alzheimer's,Asthma,IL-6 Inhibitor,Phase 3,Completed
NCT97533,Phase 2 Study of Metformin in Asthma,Type 2 Diabetes,BACE Inhibitor,Phase 2,Withdrawn
NCT81570,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,mRNA-101,Phase 1,Recruiting
NCT78354,Phase 2 Study of Metformin in Type 2 Diabetes,Alzheimer's,mRNA-101,Phase 2,Recruiting
NCT86378,Phase 2 Study of Metformin in Asthma,Asthma,Metformin,Phase 2,Completed
NCT73639,Phase 1 Study of Monoclonal Antibody in Asthma,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Withdrawn
NCT65845,Phase 1 Study of BACE Inhibitor in Rheumatoid Arthritis,Cancer,BACE Inhibitor,Phase 1,Withdrawn
NCT79640,Phase 2 Study of Metformin in Alzheimer's,Alzheimer's,BACE Inhibitor,Phase 1,Recruiting
NCT49753,Phase 3 Study of Monoclonal Antibody in Alzheimer's,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Recruiting
NCT62653,Phase 3 Study of IL-6 Inhibitor in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Withdrawn
NCT61685,Phase 3 Study of BACE Inhibitor in Type 2 Diabetes,Alzheimer's,mRNA-101,Phase 3,Completed
NCT84455,Phase 2 Study of BACE Inhibitor in Alzheimer's,Asthma,BACE Inhibitor,Phase 3,Terminated
NCT73740,Phase 2 Study of BACE Inhibitor in Cancer,Asthma,IL-6 Inhibitor,Phase 3,Terminated
NCT98488,Phase 1 Study of Metformin in Cancer,Type 2 Diabetes,Metformin,Phase 1,Recruiting
NCT72158,Phase 3 Study of Metformin in Asthma,Asthma,mRNA-101,Phase 1,Terminated
NCT25878,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Type 2 Diabetes,BACE Inhibitor,Phase 2,Withdrawn
NCT17805,Phase 3 Study of IL-6 Inhibitor in Alzheimer's,Alzheimer's,Monoclonal Antibody,Phase 1,Completed
NCT18261,Phase 2 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,Metformin,Phase 2,Terminated
NCT51814,Phase 2 Study of IL-6 Inhibitor in Asthma,Asthma,IL-6 Inhibitor,Phase 2,Recruiting
NCT80140,Phase 1 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 2,Recruiting
NCT82019,Phase 3 Study of mRNA-101 in Rheumatoid Arthritis,Type 2 Diabetes,Metformin,Phase 1,Terminated
NCT70290,Phase 3 Study of Metformin in Rheumatoid Arthritis,Type 2 Diabetes,Metformin,Phase 2,Recruiting
NCT14276,Phase 2 Study of BACE Inhibitor in Type 2 Diabetes,Asthma,BACE Inhibitor,Phase 2,Recruiting
NCT29433,Phase 1 Study of BACE Inhibitor in Cancer,Cancer,BACE Inhibitor,Phase 1,Terminated
NCT80748,Phase 2 Study of Monoclonal Antibody in Asthma,Cancer,IL-6 Inhibitor,Phase 3,Terminated
NCT36056,Phase 2 Study of BACE Inhibitor in Rheumatoid Arthritis,Cancer,Monoclonal Antibody,Phase 3,Completed
NCT64484,Phase 1 Study of IL-6 Inhibitor in Cancer,Asthma,IL-6 Inhibitor,Phase 3,Withdrawn
NCT55913,Phase 1 Study of Metformin in Asthma,Cancer,IL-6 Inhibitor,Phase 2,Recruiting
NCT81982,Phase 1 Study of Monoclonal Antibody in Rheumatoid Arthritis,Rheumatoid Arthritis,mRNA-101,Phase 2,Recruiting
NCT11571,Phase 1 Study of IL-6 Inhibitor in Asthma,Cancer,Metformin,Phase 2,Completed
NCT37246,Phase 1 Study of IL-6 Inhibitor in Asthma,Asthma,IL-6 Inhibitor,Phase 3,Terminated
NCT55795,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,mRNA-101,Phase 1,Recruiting
NCT14020,Phase 2 Study of Metformin in Alzheimer's,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 2,Recruiting
NCT17863,Phase 3 Study of IL-6 Inhibitor in Alzheimer's,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Recruiting
NCT37958,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,Metformin,Phase 1,Terminated
NCT27517,Phase 3 Study of mRNA-101 in Alzheimer's,Alzheimer's,Metformin,Phase 3,Withdrawn
NCT58411,Phase 3 Study of Metformin in Cancer,Asthma,Metformin,Phase 1,Recruiting
NCT89237,Phase 2 Study of BACE Inhibitor in Alzheimer's,Type 2 Diabetes,BACE Inhibitor,Phase 1,Terminated
NCT73442,Phase 3 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,mRNA-101,Phase 2,Terminated
NCT31269,Phase 2 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,mRNA-101,Phase 3,Recruiting
NCT77296,Phase 3 Study of Metformin in Cancer,Type 2 Diabetes,BACE Inhibitor,Phase 2,Terminated
NCT68751,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Cancer,Monoclonal Antibody,Phase 3,Completed
NCT63394,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Terminated
NCT83050,Phase 1 Study of Monoclonal Antibody in Cancer,Alzheimer's,mRNA-101,Phase 2,Recruiting
NCT65922,Phase 2 Study of Metformin in Asthma,Alzheimer's,mRNA-101,Phase 3,Recruiting
NCT90016,Phase 1 Study of Metformin in Asthma,Alzheimer's,Monoclonal Antibody,Phase 2,Terminated
NCT97242,Phase 1 Study of IL-6 Inhibitor in Alzheimer's,Alzheimer's,mRNA-101,Phase 3,Withdrawn
NCT56907,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Cancer,Monoclonal Antibody,Phase 3,Completed
NCT70787,Phase 3 Study of Monoclonal Antibody in Asthma,Type 2 Diabetes,Monoclonal Antibody,Phase 3,Withdrawn
NCT32092,Phase 3 Study of Metformin in Type 2 Diabetes,Cancer,mRNA-101,Phase 2,Terminated
NCT44030,Phase 1 Study of mRNA-101 in Asthma,Asthma,Monoclonal Antibody,Phase 3,Withdrawn
NCT14856,Phase 2 Study of BACE Inhibitor in Alzheimer's,Alzheimer's,BACE Inhibitor,Phase 3,Completed
NCT29169,Phase 1 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,BACE Inhibitor,Phase 2,Withdrawn
NCT55603,Phase 3 Study of mRNA-101 in Rheumatoid Arthritis,Asthma,mRNA-101,Phase 2,Terminated
NCT47434,Phase 2 Study of BACE Inhibitor in Rheumatoid Arthritis,Alzheimer's,mRNA-101,Phase 2,Completed
NCT21673,Phase 3 Study of BACE Inhibitor in Type 2 Diabetes,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Completed
NCT11028,Phase 1 Study of BACE Inhibitor in Asthma,Asthma,BACE Inhibitor,Phase 3,Withdrawn
NCT21645,Phase 3 Study of Metformin in Asthma,Cancer,Monoclonal Antibody,Phase 1,Completed
NCT93560,Phase 1 Study of BACE Inhibitor in Cancer,Rheumatoid Arthritis,Monoclonal Antibody,Phase 2,Recruiting
NCT50587,Phase 3 Study of BACE Inhibitor in Asthma,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Completed
NCT42481,Phase 3 Study of BACE Inhibitor in Alzheimer's,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Recruiting
NCT42819,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Type 2 Diabetes,BACE Inhibitor,Phase 2,Terminated
NCT65021,Phase 3 Study of BACE Inhibitor in Cancer,Alzheimer's,Metformin,Phase 1,Terminated
NCT85878,Phase 3 Study of Metformin in Type 2 Diabetes,Cancer,Monoclonal Antibody,Phase 1,Terminated
NCT84502,Phase 1 Study of Metformin in Cancer,Alzheimer's,IL-6 Inhibitor,Phase 1,Recruiting
NCT94591,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Asthma,Metformin,Phase 2,Recruiting
NCT33149,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Asthma,Metformin,Phase 2,Terminated
NCT81905,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Recruiting
NCT29030,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,Monoclonal Antibody,Phase 1,Withdrawn
NCT57769,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Rheumatoid Arthritis,Metformin,Phase 3,Terminated
NCT61096,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Type 2 Diabetes,Metformin,Phase 2,Terminated
NCT40231,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Withdrawn
NCT43542,Phase 2 Study of mRNA-101 in Asthma,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Terminated
NCT93306,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Withdrawn
NCT57659,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Asthma,IL-6 Inhibitor,Phase 3,Withdrawn
NCT50894,Phase 2 Study of BACE Inhibitor in Type 2 Diabetes,Type 2 Diabetes,BACE Inhibitor,Phase 3,Recruiting
NCT93387,Phase 2 Study of Metformin in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Terminated
NCT22184,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Alzheimer's,BACE Inhibitor,Phase 2,Withdrawn
NCT32268,Phase 3 Study of BACE Inhibitor in Alzheimer's,Type 2 Diabetes,Metformin,Phase 3,Completed
NCT25276,Phase 1 Study of BACE Inhibitor in Cancer,Alzheimer's,BACE Inhibitor,Phase 3,Terminated
NCT22781,Phase 3 Study of Monoclonal Antibody in Rheumatoid Arthritis,Alzheimer's,Metformin,Phase 2,Recruiting
NCT79702,Phase 3 Study of Metformin in Alzheimer's,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Completed
NCT27149,Phase 3 Study of IL-6 Inhibitor in Alzheimer's,Cancer,BACE Inhibitor,Phase 3,Withdrawn
NCT79695,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Type 2 Diabetes,BACE Inhibitor,Phase 1,Completed
NCT68271,Phase 1 Study of BACE Inhibitor in Rheumatoid Arthritis,Alzheimer's,mRNA-101,Phase 2,Completed
NCT32809,Phase 2 Study of Metformin in Type 2 Diabetes,Type 2 Diabetes,Metformin,Phase 2,Completed
NCT64284,Phase 3 Study of mRNA-101 in Alzheimer's,Type 2 Diabetes,BACE Inhibitor,Phase 2,Terminated
NCT20405,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Alzheimer's,mRNA-101,Phase 3,Recruiting
NCT45705,Phase 2 Study of mRNA-101 in Cancer,Asthma,IL-6 Inhibitor,Phase 2,Recruiting
NCT65191,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Terminated
NCT20876,Phase 1 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,mRNA-101,Phase 3,Withdrawn
NCT94173,Phase 1 Study of Metformin in Asthma,Alzheimer's,BACE Inhibitor,Phase 2,Completed
NCT50676,Phase 3 Study of Metformin in Alzheimer's,Type 2 Diabetes,mRNA-101,Phase 3,Completed
NCT15620,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,Metformin,Phase 1,Withdrawn
NCT60404,Phase 3 Study of Metformin in Asthma,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Withdrawn
NCT36619,Phase 3 Study of Metformin in Rheumatoid Arthritis,Cancer,mRNA-101,Phase 1,Terminated
NCT15258,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Completed
NCT17364,Phase 3 Study of Monoclonal Antibody in Rheumatoid Arthritis,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Terminated
NCT85445,Phase 1 Study of Metformin in Alzheimer's,Asthma,Monoclonal Antibody,Phase 2,Completed
NCT47932,Phase 2 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,mRNA-101,Phase 3,Recruiting
NCT33757,Phase 3 Study of Metformin in Alzheimer's,Cancer,Monoclonal Antibody,Phase 2,Withdrawn
NCT51698,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Completed
NCT38666,Phase 3 Study of mRNA-101 in Cancer,Asthma,BACE Inhibitor,Phase 3,Completed
NCT99381,Phase 3 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,Monoclonal Antibody,Phase 2,Completed
NCT83735,Phase 2 Study of IL-6 Inhibitor in Cancer,Type 2 Diabetes,mRNA-101,Phase 1,Withdrawn
NCT61838,Phase 2 Study of mRNA-101 in Alzheimer's,Alzheimer's,Monoclonal Antibody,Phase 1,Terminated
NCT81939,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Type 2 Diabetes,Metformin,Phase 3,Terminated
NCT45961,Phase 1 Study of Metformin in Cancer,Asthma,mRNA-101,Phase 1,Withdrawn
NCT50387,Phase 1 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,IL-6 Inhibitor,Phase 1,Terminated
NCT40149,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,BACE Inhibitor,Phase 1,Recruiting
NCT32715,Phase 1 Study of BACE Inhibitor in Alzheimer's,Cancer,IL-6 Inhibitor,Phase 3,Withdrawn
NCT39021,Phase 3 Study of Monoclonal Antibody in Alzheimer's,Asthma,IL-6 Inhibitor,Phase 1,Recruiting
NCT98742,Phase 2 Study of Monoclonal Antibody in Asthma,Alzheimer's,mRNA-101,Phase 3,Terminated
NCT35194,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 2,Terminated
NCT66781,Phase 1 Study of BACE Inhibitor in Cancer,Asthma,BACE Inhibitor,Phase 2,Completed
NCT37186,Phase 3 Study of IL-6 Inhibitor in Alzheimer's,Alzheimer's,Monoclonal Antibody,Phase 1,Terminated
NCT72159,Phase 2 Study of Metformin in Cancer,Cancer,Monoclonal Antibody,Phase 1,Terminated
NCT75548,Phase 1 Study of Monoclonal Antibody in Asthma,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Terminated
NCT60061,Phase 2 Study of Monoclonal Antibody in Asthma,Rheumatoid Arthritis,mRNA-101,Phase 2,Completed
NCT49679,Phase 3 Study of Monoclonal Antibody in Asthma,Type 2 Diabetes,BACE Inhibitor,Phase 3,Terminated
NCT35987,Phase 2 Study of BACE Inhibitor in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Recruiting
NCT54651,Phase 1 Study of Metformin in Asthma,Alzheimer's,BACE Inhibitor,Phase 1,Terminated
NCT65817,Phase 1 Study of BACE Inhibitor in Cancer,Alzheimer's,Monoclonal Antibody,Phase 2,Withdrawn
NCT64401,Phase 2 Study of mRNA-101 in Cancer,Cancer,Monoclonal Antibody,Phase 1,Terminated
NCT44526,Phase 1 Study of Metformin in Cancer,Type 2 Diabetes,Metformin,Phase 1,Completed
NCT89956,Phase 1 Study of mRNA-101 in Alzheimer's,Rheumatoid Arthritis,mRNA-101,Phase 1,Completed
NCT13270,Phase 2 Study of IL-6 Inhibitor in Asthma,Alzheimer's,BACE Inhibitor,Phase 3,Completed
NCT52272,Phase 1 Study of Metformin in Cancer,Rheumatoid Arthritis,mRNA-101,Phase 3,Terminated
NCT59710,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Terminated
NCT87912,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Alzheimer's,Metformin,Phase 1,Withdrawn
NCT38795,Phase 1 Study of BACE Inhibitor in Alzheimer's,Alzheimer's,Monoclonal Antibody,Phase 2,Terminated
NCT74135,Phase 2 Study of Monoclonal Antibody in Asthma,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Completed
NCT82828,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Alzheimer's,IL-6 Inhibitor,Phase 2,Completed
NCT25365,Phase 1 Study of Metformin in Alzheimer's,Rheumatoid Arthritis,mRNA-101,Phase 3,Recruiting
NCT72712,Phase 3 Study of IL-6 Inhibitor in Asthma,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Completed
NCT92226,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Asthma,BACE Inhibitor,Phase 3,Completed
NCT25339,Phase 2 Study of mRNA-101 in Asthma,Type 2 Diabetes,mRNA-101,Phase 2,Terminated
NCT11727,Phase 2 Study of BACE Inhibitor in Asthma,Asthma,mRNA-101,Phase 1,Completed
NCT68085,Phase 1 Study of BACE Inhibitor in Type 2 Diabetes,Type 2 Diabetes,Monoclonal Antibody,Phase 3,Completed
NCT20320,Phase 3 Study of Metformin in Cancer,Rheumatoid Arthritis,mRNA-101,Phase 1,Recruiting
NCT44182,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Asthma,mRNA-101,Phase 2,Withdrawn
NCT55002,Phase 1 Study of BACE Inhibitor in Asthma,Alzheimer's,Metformin,Phase 3,Withdrawn
NCT69116,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,BACE Inhibitor,Phase 2,Completed
NCT47777,Phase 3 Study of mRNA-101 in Asthma,Cancer,Monoclonal Antibody,Phase 3,Completed
NCT56609,Phase 2 Study of mRNA-101 in Cancer,Type 2 Diabetes,Metformin,Phase 1,Terminated
NCT19448,Phase 1 Study of mRNA-101 in Asthma,Alzheimer's,IL-6 Inhibitor,Phase 1,Recruiting
NCT98930,Phase 3 Study of Metformin in Alzheimer's,Type 2 Diabetes,BACE Inhibitor,Phase 3,Terminated
NCT58703,Phase 3 Study of Monoclonal Antibody in Cancer,Alzheimer's,Metformin,Phase 2,Terminated
NCT80335,Phase 2 Study of Metformin in Alzheimer's,Alzheimer's,mRNA-101,Phase 2,Withdrawn
NCT32812,Phase 1 Study of BACE Inhibitor in Asthma,Cancer,Monoclonal Antibody,Phase 2,Completed
NCT62994,Phase 3 Study of Metformin in Alzheimer's,Asthma,Metformin,Phase 3,Terminated
NCT40392,Phase 3 Study of mRNA-101 in Alzheimer's,Asthma,IL-6 Inhibitor,Phase 3,Terminated
NCT98522,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,Metformin,Phase 3,Completed
NCT51466,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Recruiting
NCT64705,Phase 2 Study of IL-6 Inhibitor in Asthma,Cancer,Metformin,Phase 3,Terminated
NCT36994,Phase 2 Study of BACE Inhibitor in Alzheimer's,Rheumatoid Arthritis,Metformin,Phase 2,Recruiting
NCT25439,Phase 3 Study of Monoclonal Antibody in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 3,Terminated
NCT14561,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Completed
NCT37455,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Rheumatoid Arthritis,Metformin,Phase 2,Recruiting
NCT92310,Phase 2 Study of Metformin in Alzheimer's,Asthma,Monoclonal Antibody,Phase 2,Completed
NCT52658,Phase 1 Study of Monoclonal Antibody in Alzheimer's,Asthma,BACE Inhibitor,Phase 1,Completed
NCT70266,Phase 1 Study of BACE Inhibitor in Asthma,Cancer,Monoclonal Antibody,Phase 3,Completed
NCT13058,Phase 1 Study of IL-6 Inhibitor in Asthma,Asthma,BACE Inhibitor,Phase 1,Completed
NCT28542,Phase 2 Study of BACE Inhibitor in Alzheimer's,Alzheimer's,mRNA-101,Phase 3,Withdrawn
NCT69809,Phase 2 Study of Metformin in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 2,Withdrawn
NCT32469,Phase 1 Study of Metformin in Asthma,Alzheimer's,IL-6 Inhibitor,Phase 1,Recruiting
NCT60716,Phase 1 Study of Monoclonal Antibody in Asthma,Asthma,BACE Inhibitor,Phase 1,Recruiting
NCT22966,Phase 3 Study of Metformin in Asthma,Alzheimer's,mRNA-101,Phase 3,Completed
NCT55393,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Alzheimer's,Metformin,Phase 1,Withdrawn
NCT14025,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Withdrawn
NCT56728,Phase 3 Study of mRNA-101 in Alzheimer's,Type 2 Diabetes,BACE Inhibitor,Phase 1,Withdrawn
NCT35406,Phase 2 Study of Metformin in Alzheimer's,Asthma,IL-6 Inhibitor,Phase 2,Recruiting
NCT15804,Phase 3 Study of BACE Inhibitor in Alzheimer's,Asthma,IL-6 Inhibitor,Phase 3,Completed
NCT43899,Phase 1 Study of BACE Inhibitor in Asthma,Asthma,IL-6 Inhibitor,Phase 2,Terminated
NCT69287,Phase 1 Study of Metformin in Asthma,Asthma,BACE Inhibitor,Phase 3,Completed
NCT74189,Phase 2 Study of mRNA-101 in Asthma,Alzheimer's,Metformin,Phase 2,Recruiting
NCT24876,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Asthma,IL-6 Inhibitor,Phase 1,Withdrawn
NCT95654,Phase 3 Study of Metformin in Cancer,Type 2 Diabetes,BACE Inhibitor,Phase 3,Completed
NCT95488,Phase 2 Study of IL-6 Inhibitor in Cancer,Rheumatoid Arthritis,Metformin,Phase 2,Withdrawn
NCT55231,Phase 3 Study of Monoclonal Antibody in Asthma,Alzheimer's,Monoclonal Antibody,Phase 2,Withdrawn
NCT42131,Phase 3 Study of Metformin in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 1,Recruiting
NCT59238,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Cancer,BACE Inhibitor,Phase 1,Terminated
NCT80951,Phase 2 Study of mRNA-101 in Asthma,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Completed
NCT84989,Phase 3 Study of Metformin in Asthma,Rheumatoid Arthritis,mRNA-101,Phase 1,Completed
NCT53758,Phase 3 Study of mRNA-101 in Asthma,Type 2 Diabetes,mRNA-101,Phase 2,Completed
NCT92020,Phase 2 Study of mRNA-101 in Cancer,Type 2 Diabetes,BACE Inhibitor,Phase 3,Completed
NCT12974,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Type 2 Diabetes,Metformin,Phase 3,Recruiting
NCT61107,Phase 3 Study of Metformin in Rheumatoid Arthritis,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Completed
NCT66324,Phase 1 Study of BACE Inhibitor in Type 2 Diabetes,Cancer,Monoclonal Antibody,Phase 1,Completed
NCT47115,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Alzheimer's,Monoclonal Antibody,Phase 3,Terminated
NCT18580,Phase 3 Study of BACE Inhibitor in Asthma,Asthma,Metformin,Phase 1,Completed
NCT15096,Phase 1 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,BACE Inhibitor,Phase 1,Withdrawn
NCT57169,Phase 3 Study of mRNA-101 in Asthma,Type 2 Diabetes,Metformin,Phase 3,Withdrawn
NCT15142,Phase 3 Study of BACE Inhibitor in Asthma,Type 2 Diabetes,Monoclonal Antibody,Phase 3,Withdrawn
NCT19451,Phase 3 Study of mRNA-101 in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Recruiting
NCT86947,Phase 2 Study of Metformin in Asthma,Alzheimer's,IL-6 Inhibitor,Phase 2,Completed
NCT27144,Phase 1 Study of IL-6 Inhibitor in Asthma,Type 2 Diabetes,BACE Inhibitor,Phase 1,Withdrawn
NCT19172,Phase 2 Study of Metformin in Rheumatoid Arthritis,Alzheimer's,BACE Inhibitor,Phase 1,Completed
NCT13228,Phase 3 Study of Monoclonal Antibody in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Terminated
NCT81727,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 2,Terminated
NCT86227,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Asthma,BACE Inhibitor,Phase 1,Completed
NCT21713,Phase 1 Study of IL-6 Inhibitor in Alzheimer's,Cancer,BACE Inhibitor,Phase 1,Terminated
NCT57277,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 1,Completed
NCT81540,Phase 1 Study of IL-6 Inhibitor in Cancer,Cancer,BACE Inhibitor,Phase 1,Completed
NCT17128,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Cancer,IL-6 Inhibitor,Phase 1,Terminated
NCT18662,Phase 1 Study of BACE Inhibitor in Asthma,Asthma,BACE Inhibitor,Phase 3,Withdrawn
NCT17730,Phase 1 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,Metformin,Phase 2,Terminated
NCT58084,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Cancer,Monoclonal Antibody,Phase 1,Completed
NCT58217,Phase 1 Study of BACE Inhibitor in Cancer,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Terminated
NCT39935,Phase 3 Study of BACE Inhibitor in Alzheimer's,Cancer,Metformin,Phase 1,Terminated
NCT85359,Phase 1 Study of Metformin in Alzheimer's,Cancer,mRNA-101,Phase 2,Withdrawn
NCT64275,Phase 1 Study of Monoclonal Antibody in Asthma,Asthma,Monoclonal Antibody,Phase 1,Completed
NCT21741,Phase 3 Study of Monoclonal Antibody in Asthma,Asthma,BACE Inhibitor,Phase 1,Completed
NCT99251,Phase 3 Study of mRNA-101 in Alzheimer's,Alzheimer's,BACE Inhibitor,Phase 1,Terminated
NCT17183,Phase 3 Study of mRNA-101 in Alzheimer's,Rheumatoid Arthritis,Metformin,Phase 1,Completed
NCT69241,Phase 3 Study of BACE Inhibitor in Asthma,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Withdrawn
NCT21073,Phase 3 Study of BACE Inhibitor in Cancer,Alzheimer's,Monoclonal Antibody,Phase 3,Completed
NCT67226,Phase 3 Study of Monoclonal Antibody in Cancer,Asthma,IL-6 Inhibitor,Phase 1,Withdrawn
NCT55349,Phase 3 Study of Metformin in Type 2 Diabetes,Alzheimer's,Metformin,Phase 2,Recruiting
NCT50660,Phase 3 Study of BACE Inhibitor in Cancer,Type 2 Diabetes,mRNA-101,Phase 1,Completed
NCT35081,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 2,Withdrawn
NCT71472,Phase 3 Study of mRNA-101 in Asthma,Asthma,Monoclonal Antibody,Phase 1,Completed
NCT94863,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Asthma,BACE Inhibitor,Phase 3,Completed
NCT63273,Phase 3 Study of Metformin in Asthma,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Withdrawn
NCT85016,Phase 2 Study of Monoclonal Antibody in Cancer,Cancer,mRNA-101,Phase 2,Completed
NCT29307,Phase 2 Study of Monoclonal Antibody in Asthma,Asthma,BACE Inhibitor,Phase 1,Withdrawn
NCT10596,Phase 1 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Type 2 Diabetes,mRNA-101,Phase 1,Withdrawn
NCT49461,Phase 2 Study of BACE Inhibitor in Alzheimer's,Rheumatoid Arthritis,Metformin,Phase 1,Withdrawn
NCT81163,Phase 2 Study of BACE Inhibitor in Asthma,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Completed
NCT33752,Phase 2 Study of IL-6 Inhibitor in Cancer,Type 2 Diabetes,BACE Inhibitor,Phase 2,Terminated
NCT56743,Phase 2 Study of BACE Inhibitor in Cancer,Type 2 Diabetes,mRNA-101,Phase 1,Recruiting
NCT67746,Phase 1 Study of Metformin in Alzheimer's,Alzheimer's,Metformin,Phase 3,Recruiting
NCT43707,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Type 2 Diabetes,mRNA-101,Phase 2,Completed
NCT58245,Phase 1 Study of BACE Inhibitor in Cancer,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Recruiting
NCT69435,Phase 1 Study of Monoclonal Antibody in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 1,Completed
NCT19851,Phase 3 Study of IL-6 Inhibitor in Cancer,Cancer,IL-6 Inhibitor,Phase 2,Withdrawn
NCT45964,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 3,Terminated
NCT99110,Phase 2 Study of BACE Inhibitor in Asthma,Alzheimer's,Metformin,Phase 2,Completed
NCT13918,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Alzheimer's,Metformin,Phase 1,Terminated
NCT94963,Phase 3 Study of IL-6 Inhibitor in Alzheimer's,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Completed
NCT94036,Phase 2 Study of mRNA-101 in Asthma,Asthma,mRNA-101,Phase 2,Recruiting
NCT36926,Phase 1 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,mRNA-101,Phase 2,Recruiting
NCT87418,Phase 1 Study of Metformin in Rheumatoid Arthritis,Cancer,Monoclonal Antibody,Phase 2,Completed
NCT69728,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Asthma,Metformin,Phase 1,Withdrawn
NCT46261,Phase 2 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,mRNA-101,Phase 1,Withdrawn
NCT24958,Phase 2 Study of BACE Inhibitor in Cancer,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Withdrawn
NCT35378,Phase 1 Study of Metformin in Type 2 Diabetes,Asthma,IL-6 Inhibitor,Phase 1,Terminated
NCT93185,Phase 3 Study of IL-6 Inhibitor in Asthma,Type 2 Diabetes,Metformin,Phase 2,Terminated
NCT92739,Phase 2 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,mRNA-101,Phase 2,Recruiting
NCT52531,Phase 3 Study of Metformin in Cancer,Cancer,IL-6 Inhibitor,Phase 2,Recruiting
NCT45082,Phase 1 Study of BACE Inhibitor in Alzheimer's,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Terminated
NCT89318,Phase 2 Study of mRNA-101 in Cancer,Asthma,BACE Inhibitor,Phase 1,Terminated
NCT60246,Phase 2 Study of BACE Inhibitor in Cancer,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Terminated
NCT23388,Phase 2 Study of mRNA-101 in Alzheimer's,Asthma,BACE Inhibitor,Phase 3,Recruiting
NCT32240,Phase 3 Study of IL-6 Inhibitor in Alzheimer's,Alzheimer's,Metformin,Phase 2,Terminated
NCT54823,Phase 2 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Withdrawn
NCT25361,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Type 2 Diabetes,Metformin,Phase 3,Withdrawn
NCT35501,Phase 3 Study of BACE Inhibitor in Cancer,Type 2 Diabetes,BACE Inhibitor,Phase 2,Withdrawn
NCT67980,Phase 3 Study of Metformin in Cancer,Alzheimer's,IL-6 Inhibitor,Phase 2,Terminated
NCT35601,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,IL-6 Inhibitor,Phase 1,Recruiting
NCT43063,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Alzheimer's,mRNA-101,Phase 3,Terminated
NCT27255,Phase 2 Study of Monoclonal Antibody in Asthma,Cancer,BACE Inhibitor,Phase 2,Terminated
NCT42186,Phase 3 Study of BACE Inhibitor in Asthma,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Recruiting
NCT41951,Phase 1 Study of Metformin in Alzheimer's,Asthma,Metformin,Phase 2,Recruiting
NCT63067,Phase 1 Study of IL-6 Inhibitor in Cancer,Cancer,Metformin,Phase 2,Completed
NCT26010,Phase 3 Study of BACE Inhibitor in Type 2 Diabetes,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Terminated
NCT34270,Phase 3 Study of Metformin in Cancer,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Terminated
NCT81880,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,mRNA-101,Phase 2,Recruiting
NCT99457,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Cancer,Monoclonal Antibody,Phase 3,Recruiting
NCT25743,Phase 1 Study of Metformin in Cancer,Alzheimer's,mRNA-101,Phase 2,Recruiting
NCT72688,Phase 2 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,Metformin,Phase 1,Withdrawn
NCT56813,Phase 3 Study of BACE Inhibitor in Asthma,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 2,Recruiting
NCT36151,Phase 1 Study of Metformin in Rheumatoid Arthritis,Alzheimer's,IL-6 Inhibitor,Phase 1,Terminated
NCT76079,Phase 2 Study of Metformin in Type 2 Diabetes,Rheumatoid Arthritis,mRNA-101,Phase 1,Withdrawn
NCT83627,Phase 2 Study of mRNA-101 in Rheumatoid Arthritis,Alzheimer's,mRNA-101,Phase 3,Recruiting
NCT88762,Phase 3 Study of Metformin in Rheumatoid Arthritis,Type 2 Diabetes,mRNA-101,Phase 1,Completed
NCT66903,Phase 1 Study of Metformin in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 2,Recruiting
NCT71669,Phase 3 Study of Metformin in Asthma,Type 2 Diabetes,mRNA-101,Phase 1,Completed
NCT14173,Phase 2 Study of BACE Inhibitor in Asthma,Alzheimer's,mRNA-101,Phase 2,Withdrawn
NCT79494,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,mRNA-101,Phase 2,Completed
NCT42363,Phase 2 Study of mRNA-101 in Asthma,Cancer,Metformin,Phase 1,Terminated
NCT42466,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Asthma,mRNA-101,Phase 2,Recruiting
NCT34132,Phase 2 Study of Metformin in Rheumatoid Arthritis,Alzheimer's,Metformin,Phase 2,Recruiting
NCT96824,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Type 2 Diabetes,mRNA-101,Phase 2,Terminated
NCT42560,Phase 1 Study of BACE Inhibitor in Asthma,Cancer,BACE Inhibitor,Phase 3,Completed
NCT75660,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 2,Recruiting
NCT89756,Phase 1 Study of Metformin in Asthma,Cancer,IL-6 Inhibitor,Phase 1,Withdrawn
NCT27996,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Type 2 Diabetes,BACE Inhibitor,Phase 2,Recruiting
NCT30287,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Withdrawn
NCT28366,Phase 1 Study of IL-6 Inhibitor in Asthma,Asthma,Metformin,Phase 1,Recruiting
NCT86965,Phase 3 Study of Metformin in Rheumatoid Arthritis,Cancer,Monoclonal Antibody,Phase 2,Withdrawn
NCT10375,Phase 2 Study of Metformin in Alzheimer's,Type 2 Diabetes,mRNA-101,Phase 3,Recruiting
NCT40512,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Terminated
NCT25388,Phase 3 Study of BACE Inhibitor in Alzheimer's,Type 2 Diabetes,mRNA-101,Phase 3,Withdrawn
NCT24561,Phase 3 Study of Metformin in Alzheimer's,Alzheimer's,BACE Inhibitor,Phase 2,Terminated
NCT38372,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,Metformin,Phase 1,Terminated
NCT50511,Phase 3 Study of BACE Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 2,Withdrawn
NCT45045,Phase 3 Study of mRNA-101 in Alzheimer's,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Terminated
NCT58702,Phase 2 Study of IL-6 Inhibitor in Cancer,Cancer,Monoclonal Antibody,Phase 2,Completed
NCT59262,Phase 2 Study of BACE Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,mRNA-101,Phase 2,Completed
NCT90405,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Withdrawn
NCT50414,Phase 3 Study of Metformin in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Completed
NCT55733,Phase 1 Study of Monoclonal Antibody in Alzheimer's,Asthma,Metformin,Phase 1,Withdrawn
NCT81190,Phase 2 Study of mRNA-101 in Rheumatoid Arthritis,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Completed
NCT85263,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,BACE Inhibitor,Phase 1,Recruiting
NCT46974,Phase 2 Study of IL-6 Inhibitor in Asthma,Cancer,BACE Inhibitor,Phase 2,Recruiting
NCT12693,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Asthma,Metformin,Phase 2,Withdrawn
NCT78281,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Completed
NCT27732,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Terminated
NCT23556,Phase 1 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Completed
NCT48127,Phase 2 Study of mRNA-101 in Rheumatoid Arthritis,Cancer,mRNA-101,Phase 1,Completed
NCT20930,Phase 2 Study of mRNA-101 in Asthma,Asthma,BACE Inhibitor,Phase 1,Completed
NCT78676,Phase 1 Study of Metformin in Asthma,Type 2 Diabetes,Metformin,Phase 3,Recruiting
NCT94163,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Recruiting
NCT50501,Phase 2 Study of IL-6 Inhibitor in Cancer,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Terminated
NCT25123,Phase 3 Study of Metformin in Cancer,Cancer,Metformin,Phase 3,Completed
NCT72112,Phase 1 Study of Monoclonal Antibody in Alzheimer's,Asthma,BACE Inhibitor,Phase 2,Terminated
NCT45241,Phase 1 Study of BACE Inhibitor in Rheumatoid Arthritis,Asthma,BACE Inhibitor,Phase 1,Completed
NCT62657,Phase 3 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,Metformin,Phase 2,Withdrawn
NCT71717,Phase 1 Study of Monoclonal Antibody in Alzheimer's,Asthma,Monoclonal Antibody,Phase 3,Recruiting
NCT27923,Phase 1 Study of BACE Inhibitor in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 3,Completed
NCT69572,Phase 1 Study of BACE Inhibitor in Rheumatoid Arthritis,Alzheimer's,mRNA-101,Phase 2,Recruiting
NCT82816,Phase 3 Study of IL-6 Inhibitor in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Withdrawn
NCT74435,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Cancer,Monoclonal Antibody,Phase 1,Terminated
NCT65131,Phase 2 Study of BACE Inhibitor in Cancer,Cancer,BACE Inhibitor,Phase 3,Recruiting
NCT72362,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 2,Completed
NCT97079,Phase 3 Study of Monoclonal Antibody in Cancer,Asthma,BACE Inhibitor,Phase 2,Withdrawn
NCT43587,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 1,Recruiting
NCT77939,Phase 1 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Completed
NCT56675,Phase 1 Study of Metformin in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 2,Completed
NCT74967,Phase 1 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 1,Withdrawn
NCT62680,Phase 2 Study of Monoclonal Antibody in Asthma,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Withdrawn
NCT91929,Phase 1 Study of BACE Inhibitor in Type 2 Diabetes,Cancer,Metformin,Phase 1,Withdrawn
NCT69884,Phase 1 Study of Monoclonal Antibody in Asthma,Rheumatoid Arthritis,Metformin,Phase 1,Terminated
NCT58971,Phase 1 Study of mRNA-101 in Cancer,Alzheimer's,Metformin,Phase 2,Withdrawn
NCT62492,Phase 3 Study of Monoclonal Antibody in Cancer,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Completed
NCT51265,Phase 2 Study of BACE Inhibitor in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Terminated
NCT83825,Phase 3 Study of Metformin in Rheumatoid Arthritis,Cancer,mRNA-101,Phase 1,Recruiting
NCT30528,Phase 2 Study of Monoclonal Antibody in Asthma,Cancer,BACE Inhibitor,Phase 1,Recruiting
NCT57323,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Terminated
NCT56686,Phase 2 Study of Monoclonal Antibody in Cancer,Alzheimer's,Metformin,Phase 1,Terminated
NCT60012,Phase 3 Study of Metformin in Asthma,Type 2 Diabetes,BACE Inhibitor,Phase 1,Withdrawn
NCT55342,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Withdrawn
NCT19175,Phase 3 Study of IL-6 Inhibitor in Alzheimer's,Type 2 Diabetes,mRNA-101,Phase 1,Withdrawn
NCT25174,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Type 2 Diabetes,BACE Inhibitor,Phase 2,Terminated
NCT69667,Phase 1 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 3,Withdrawn
NCT18189,Phase 1 Study of Monoclonal Antibody in Asthma,Cancer,BACE Inhibitor,Phase 2,Recruiting
NCT61380,Phase 3 Study of Metformin in Alzheimer's,Type 2 Diabetes,BACE Inhibitor,Phase 1,Recruiting
NCT71252,Phase 3 Study of mRNA-101 in Asthma,Cancer,IL-6 Inhibitor,Phase 1,Terminated
NCT40431,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Cancer,Metformin,Phase 2,Completed
NCT35659,Phase 3 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Terminated
NCT26214,Phase 2 Study of BACE Inhibitor in Alzheimer's,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Recruiting
NCT68949,Phase 3 Study of mRNA-101 in Asthma,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Terminated
NCT99206,Phase 1 Study of BACE Inhibitor in Cancer,Cancer,IL-6 Inhibitor,Phase 3,Terminated
NCT23499,Phase 1 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Recruiting
NCT16833,Phase 2 Study of BACE Inhibitor in Cancer,Cancer,Monoclonal Antibody,Phase 3,Terminated
NCT96438,Phase 1 Study of IL-6 Inhibitor in Alzheimer's,Asthma,Monoclonal Antibody,Phase 2,Withdrawn
NCT95851,Phase 3 Study of BACE Inhibitor in Cancer,Cancer,BACE Inhibitor,Phase 1,Recruiting
NCT49607,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Terminated
NCT69418,Phase 1 Study of Monoclonal Antibody in Type 2 Diabetes,Alzheimer's,BACE Inhibitor,Phase 3,Recruiting
NCT20432,Phase 1 Study of BACE Inhibitor in Asthma,Cancer,IL-6 Inhibitor,Phase 1,Withdrawn
NCT49017,Phase 2 Study of BACE Inhibitor in Rheumatoid Arthritis,Alzheimer's,Metformin,Phase 3,Terminated
NCT13084,Phase 1 Study of Metformin in Type 2 Diabetes,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Completed
NCT54300,Phase 3 Study of Metformin in Asthma,Alzheimer's,Monoclonal Antibody,Phase 1,Recruiting
NCT82225,Phase 2 Study of BACE Inhibitor in Alzheimer's,Asthma,Metformin,Phase 3,Completed
NCT91381,Phase 1 Study of BACE Inhibitor in Alzheimer's,Alzheimer's,mRNA-101,Phase 1,Completed
NCT49240,Phase 1 Study of mRNA-101 in Alzheimer's,Cancer,BACE Inhibitor,Phase 3,Recruiting
NCT55631,Phase 3 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,mRNA-101,Phase 3,Recruiting
NCT55639,Phase 2 Study of Metformin in Cancer,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Terminated
NCT77645,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Cancer,IL-6 Inhibitor,Phase 1,Recruiting
NCT64938,Phase 3 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,Metformin,Phase 1,Recruiting
NCT54227,Phase 3 Study of Monoclonal Antibody in Asthma,Type 2 Diabetes,Metformin,Phase 3,Terminated
NCT33706,Phase 1 Study of Metformin in Asthma,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Completed
NCT63227,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Type 2 Diabetes,BACE Inhibitor,Phase 2,Completed
NCT18882,Phase 3 Study of IL-6 Inhibitor in Asthma,Alzheimer's,mRNA-101,Phase 1,Recruiting
NCT31728,Phase 1 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,IL-6 Inhibitor,Phase 1,Recruiting
NCT85206,Phase 3 Study of BACE Inhibitor in Asthma,Cancer,mRNA-101,Phase 1,Recruiting
NCT24093,Phase 1 Study of IL-6 Inhibitor in Asthma,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Terminated
NCT10099,Phase 3 Study of BACE Inhibitor in Asthma,Alzheimer's,Metformin,Phase 2,Recruiting
NCT73614,Phase 2 Study of Metformin in Type 2 Diabetes,Rheumatoid Arthritis,mRNA-101,Phase 2,Completed
NCT57980,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Cancer,Metformin,Phase 1,Recruiting
NCT90373,Phase 2 Study of Monoclonal Antibody in Asthma,Alzheimer's,Metformin,Phase 2,Withdrawn
NCT97248,Phase 1 Study of mRNA-101 in Alzheimer's,Asthma,mRNA-101,Phase 2,Withdrawn
NCT56115,Phase 2 Study of Metformin in Type 2 Diabetes,Asthma,Metformin,Phase 2,Terminated
NCT68283,Phase 3 Study of mRNA-101 in Cancer,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Recruiting
NCT31285,Phase 1 Study of BACE Inhibitor in Type 2 Diabetes,Type 2 Diabetes,Metformin,Phase 2,Terminated
NCT39889,Phase 2 Study of mRNA-101 in Rheumatoid Arthritis,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Terminated
NCT52651,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Recruiting
NCT24937,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Type 2 Diabetes,mRNA-101,Phase 1,Terminated
NCT88027,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Cancer,BACE Inhibitor,Phase 3,Completed
NCT86752,Phase 2 Study of mRNA-101 in Cancer,Alzheimer's,Metformin,Phase 2,Completed
NCT94893,Phase 1 Study of Monoclonal Antibody in Cancer,Cancer,Metformin,Phase 2,Completed
NCT40695,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Terminated
NCT89683,Phase 2 Study of BACE Inhibitor in Rheumatoid Arthritis,Alzheimer's,IL-6 Inhibitor,Phase 3,Recruiting
NCT89788,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Cancer,Monoclonal Antibody,Phase 1,Withdrawn
NCT80920,Phase 2 Study of Metformin in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 3,Withdrawn
NCT54499,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Recruiting
NCT91826,Phase 2 Study of mRNA-101 in Rheumatoid Arthritis,Alzheimer's,IL-6 Inhibitor,Phase 1,Terminated
NCT39313,Phase 1 Study of IL-6 Inhibitor in Asthma,Asthma,mRNA-101,Phase 1,Completed
NCT78523,Phase 2 Study of BACE Inhibitor in Type 2 Diabetes,Type 2 Diabetes,Metformin,Phase 3,Terminated
NCT55896,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Rheumatoid Arthritis,mRNA-101,Phase 1,Withdrawn
NCT57303,Phase 3 Study of Metformin in Asthma,Rheumatoid Arthritis,Metformin,Phase 1,Terminated
NCT71754,Phase 2 Study of BACE Inhibitor in Cancer,Asthma,Metformin,Phase 3,Completed
NCT69115,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 1,Recruiting
NCT17641,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Recruiting
NCT79232,Phase 3 Study of Monoclonal Antibody in Cancer,Rheumatoid Arthritis,mRNA-101,Phase 1,Terminated
NCT62751,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Rheumatoid Arthritis,Metformin,Phase 2,Completed
NCT64394,Phase 1 Study of Monoclonal Antibody in Type 2 Diabetes,Alzheimer's,Metformin,Phase 1,Completed
NCT19257,Phase 1 Study of BACE Inhibitor in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 2,Recruiting
NCT26937,Phase 1 Study of BACE Inhibitor in Cancer,Asthma,Monoclonal Antibody,Phase 1,Completed
NCT11171,Phase 2 Study of mRNA-101 in Asthma,Type 2 Diabetes,mRNA-101,Phase 2,Completed
NCT53863,Phase 2 Study of Metformin in Asthma,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Withdrawn
NCT57180,Phase 1 Study of BACE Inhibitor in Alzheimer's,Cancer,IL-6 Inhibitor,Phase 2,Recruiting
NCT24510,Phase 1 Study of mRNA-101 in Alzheimer's,Asthma,Monoclonal Antibody,Phase 2,Recruiting
NCT19299,Phase 1 Study of Metformin in Cancer,Rheumatoid Arthritis,Metformin,Phase 3,Terminated
NCT72771,Phase 3 Study of mRNA-101 in Rheumatoid Arthritis,Alzheimer's,Metformin,Phase 1,Withdrawn
NCT34219,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Cancer,IL-6 Inhibitor,Phase 3,Completed
NCT49508,Phase 2 Study of BACE Inhibitor in Asthma,Alzheimer's,Monoclonal Antibody,Phase 3,Completed
NCT24516,Phase 1 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 1,Withdrawn
NCT68230,Phase 2 Study of Metformin in Asthma,Cancer,mRNA-101,Phase 1,Terminated
NCT72618,Phase 3 Study of Metformin in Cancer,Asthma,IL-6 Inhibitor,Phase 3,Withdrawn
NCT68715,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Asthma,BACE Inhibitor,Phase 1,Recruiting
NCT94865,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Recruiting
NCT24938,Phase 1 Study of Metformin in Rheumatoid Arthritis,Cancer,Monoclonal Antibody,Phase 1,Terminated
NCT81638,Phase 3 Study of mRNA-101 in Alzheimer's,Alzheimer's,Monoclonal Antibody,Phase 3,Recruiting
NCT12819,Phase 3 Study of Metformin in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 2,Withdrawn
NCT17709,Phase 1 Study of BACE Inhibitor in Rheumatoid Arthritis,Asthma,mRNA-101,Phase 2,Completed
NCT95336,Phase 1 Study of BACE Inhibitor in Alzheimer's,Cancer,Monoclonal Antibody,Phase 3,Terminated
NCT86474,Phase 1 Study of IL-6 Inhibitor in Alzheimer's,Type 2 Diabetes,Metformin,Phase 1,Completed
NCT51626,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Cancer,mRNA-101,Phase 3,Recruiting
NCT84839,Phase 2 Study of BACE Inhibitor in Rheumatoid Arthritis,Cancer,BACE Inhibitor,Phase 2,Terminated
NCT86802,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Type 2 Diabetes,mRNA-101,Phase 3,Withdrawn
NCT32739,Phase 2 Study of BACE Inhibitor in Asthma,Type 2 Diabetes,BACE Inhibitor,Phase 3,Withdrawn
NCT96181,Phase 1 Study of IL-6 Inhibitor in Asthma,Alzheimer's,mRNA-101,Phase 2,Completed
NCT63663,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 2,Recruiting
NCT15792,Phase 1 Study of Metformin in Alzheimer's,Rheumatoid Arthritis,mRNA-101,Phase 3,Recruiting
NCT37534,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Cancer,mRNA-101,Phase 3,Withdrawn
NCT53398,Phase 1 Study of BACE Inhibitor in Rheumatoid Arthritis,Cancer,Monoclonal Antibody,Phase 2,Recruiting
NCT44583,Phase 1 Study of IL-6 Inhibitor in Cancer,Asthma,BACE Inhibitor,Phase 3,Recruiting
NCT50754,Phase 1 Study of Monoclonal Antibody in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 1,Completed
NCT30785,Phase 1 Study of Metformin in Cancer,Asthma,BACE Inhibitor,Phase 2,Terminated
NCT59534,Phase 3 Study of BACE Inhibitor in Alzheimer's,Alzheimer's,mRNA-101,Phase 2,Completed
NCT91729,Phase 3 Study of IL-6 Inhibitor in Alzheimer's,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Withdrawn
NCT27756,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,Metformin,Phase 1,Completed
NCT28392,Phase 2 Study of BACE Inhibitor in Asthma,Asthma,BACE Inhibitor,Phase 2,Withdrawn
NCT62230,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Recruiting
NCT58726,Phase 1 Study of mRNA-101 in Asthma,Asthma,mRNA-101,Phase 3,Recruiting
NCT77430,Phase 2 Study of Metformin in Asthma,Alzheimer's,BACE Inhibitor,Phase 1,Recruiting
NCT75791,Phase 1 Study of mRNA-101 in Alzheimer's,Cancer,BACE Inhibitor,Phase 1,Completed
NCT84453,Phase 3 Study of Metformin in Type 2 Diabetes,Asthma,BACE Inhibitor,Phase 3,Withdrawn
NCT17232,Phase 2 Study of Monoclonal Antibody in Cancer,Cancer,mRNA-101,Phase 3,Withdrawn
NCT26126,Phase 1 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,Metformin,Phase 3,Terminated
NCT16703,Phase 2 Study of BACE Inhibitor in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 3,Completed
NCT94334,Phase 3 Study of Monoclonal Antibody in Alzheimer's,Cancer,mRNA-101,Phase 1,Terminated
NCT67028,Phase 3 Study of BACE Inhibitor in Alzheimer's,Type 2 Diabetes,Metformin,Phase 1,Terminated
NCT16804,Phase 2 Study of IL-6 Inhibitor in Cancer,Asthma,IL-6 Inhibitor,Phase 2,Recruiting
NCT95322,Phase 3 Study of Metformin in Cancer,Cancer,mRNA-101,Phase 3,Recruiting
NCT26838,Phase 2 Study of Metformin in Asthma,Cancer,IL-6 Inhibitor,Phase 3,Terminated
NCT88736,Phase 2 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Recruiting
NCT33073,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,IL-6 Inhibitor,Phase 2,Withdrawn
NCT15430,Phase 1 Study of BACE Inhibitor in Rheumatoid Arthritis,Cancer,BACE Inhibitor,Phase 2,Recruiting
NCT18237,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Asthma,BACE Inhibitor,Phase 1,Recruiting
NCT67386,Phase 1 Study of Monoclonal Antibody in Asthma,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Completed
NCT19144,Phase 1 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Recruiting
NCT97180,Phase 1 Study of Metformin in Asthma,Alzheimer's,IL-6 Inhibitor,Phase 1,Withdrawn
NCT95291,Phase 3 Study of mRNA-101 in Alzheimer's,Type 2 Diabetes,mRNA-101,Phase 1,Recruiting
NCT34898,Phase 2 Study of mRNA-101 in Cancer,Cancer,Monoclonal Antibody,Phase 3,Recruiting
NCT92776,Phase 2 Study of Metformin in Type 2 Diabetes,Type 2 Diabetes,Metformin,Phase 1,Completed
NCT24479,Phase 2 Study of Metformin in Asthma,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Completed
NCT66513,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Alzheimer's,IL-6 Inhibitor,Phase 2,Completed
NCT81743,Phase 1 Study of BACE Inhibitor in Alzheimer's,Cancer,mRNA-101,Phase 1,Recruiting
NCT30457,Phase 3 Study of mRNA-101 in Cancer,Cancer,BACE Inhibitor,Phase 3,Withdrawn
NCT57524,Phase 1 Study of Monoclonal Antibody in Type 2 Diabetes,Asthma,Metformin,Phase 2,Terminated
NCT46561,Phase 2 Study of BACE Inhibitor in Alzheimer's,Rheumatoid Arthritis,Monoclonal Antibody,Phase 2,Terminated
NCT53591,Phase 2 Study of Monoclonal Antibody in Asthma,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Recruiting
NCT85375,Phase 1 Study of Monoclonal Antibody in Rheumatoid Arthritis,Cancer,mRNA-101,Phase 2,Withdrawn
NCT22077,Phase 2 Study of Metformin in Alzheimer's,Alzheimer's,Metformin,Phase 3,Recruiting
NCT11841,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Alzheimer's,Monoclonal Antibody,Phase 1,Completed
NCT64638,Phase 1 Study of BACE Inhibitor in Cancer,Alzheimer's,mRNA-101,Phase 1,Recruiting
NCT57818,Phase 1 Study of BACE Inhibitor in Alzheimer's,Alzheimer's,Monoclonal Antibody,Phase 3,Terminated
NCT69053,Phase 1 Study of IL-6 Inhibitor in Cancer,Type 2 Diabetes,BACE Inhibitor,Phase 3,Terminated
NCT81800,Phase 1 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 1,Terminated
NCT13823,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Alzheimer's,BACE Inhibitor,Phase 3,Recruiting
NCT30273,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Terminated
NCT70015,Phase 1 Study of IL-6 Inhibitor in Asthma,Rheumatoid Arthritis,mRNA-101,Phase 1,Withdrawn
NCT59982,Phase 3 Study of BACE Inhibitor in Type 2 Diabetes,Asthma,Metformin,Phase 2,Recruiting
NCT89902,Phase 3 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,Metformin,Phase 2,Terminated
NCT12272,Phase 1 Study of BACE Inhibitor in Type 2 Diabetes,Alzheimer's,mRNA-101,Phase 1,Terminated
NCT16230,Phase 3 Study of mRNA-101 in Cancer,Cancer,Monoclonal Antibody,Phase 2,Recruiting
NCT50395,Phase 2 Study of BACE Inhibitor in Alzheimer's,Asthma,BACE Inhibitor,Phase 3,Terminated
NCT92890,Phase 3 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Recruiting
NCT73732,Phase 1 Study of mRNA-101 in Cancer,Cancer,Metformin,Phase 1,Withdrawn
NCT97212,Phase 3 Study of IL-6 Inhibitor in Alzheimer's,Rheumatoid Arthritis,Monoclonal Antibody,Phase 2,Recruiting
NCT49621,Phase 1 Study of mRNA-101 in Alzheimer's,Alzheimer's,IL-6 Inhibitor,Phase 3,Withdrawn
NCT93280,Phase 1 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Alzheimer's,IL-6 Inhibitor,Phase 3,Completed
NCT92276,Phase 2 Study of Metformin in Alzheimer's,Rheumatoid Arthritis,mRNA-101,Phase 3,Recruiting
NCT48788,Phase 2 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 2,Withdrawn
NCT11276,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Type 2 Diabetes,Metformin,Phase 2,Withdrawn
NCT24395,Phase 3 Study of Monoclonal Antibody in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 2,Withdrawn
NCT85475,Phase 1 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Completed
NCT57511,Phase 1 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,mRNA-101,Phase 3,Terminated
NCT76777,Phase 1 Study of BACE Inhibitor in Alzheimer's,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Withdrawn
NCT34056,Phase 2 Study of BACE Inhibitor in Cancer,Cancer,mRNA-101,Phase 2,Withdrawn
NCT94672,Phase 3 Study of mRNA-101 in Cancer,Type 2 Diabetes,BACE Inhibitor,Phase 2,Recruiting
NCT46290,Phase 2 Study of mRNA-101 in Cancer,Asthma,mRNA-101,Phase 2,Recruiting
NCT90680,Phase 1 Study of Monoclonal Antibody in Cancer,Asthma,IL-6 Inhibitor,Phase 3,Withdrawn
NCT57815,Phase 1 Study of IL-6 Inhibitor in Asthma,Type 2 Diabetes,mRNA-101,Phase 3,Terminated
NCT54063,Phase 2 Study of Metformin in Cancer,Type 2 Diabetes,Metformin,Phase 3,Completed
NCT13248,Phase 1 Study of IL-6 Inhibitor in Asthma,Cancer,IL-6 Inhibitor,Phase 1,Recruiting
NCT92011,Phase 2 Study of BACE Inhibitor in Rheumatoid Arthritis,Cancer,mRNA-101,Phase 1,Withdrawn
NCT63282,Phase 1 Study of Monoclonal Antibody in Rheumatoid Arthritis,Asthma,BACE Inhibitor,Phase 3,Withdrawn
NCT24072,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Cancer,IL-6 Inhibitor,Phase 2,Withdrawn
NCT54179,Phase 3 Study of BACE Inhibitor in Asthma,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Terminated
NCT24678,Phase 1 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 2,Completed
NCT52188,Phase 1 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,mRNA-101,Phase 2,Completed
NCT65016,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 1,Completed
NCT15563,Phase 3 Study of BACE Inhibitor in Asthma,Alzheimer's,mRNA-101,Phase 1,Recruiting
NCT72726,Phase 2 Study of IL-6 Inhibitor in Cancer,Asthma,Metformin,Phase 2,Withdrawn
NCT53806,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Rheumatoid Arthritis,Metformin,Phase 1,Recruiting
NCT37831,Phase 2 Study of IL-6 Inhibitor in Cancer,Cancer,mRNA-101,Phase 3,Withdrawn
NCT81745,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,mRNA-101,Phase 1,Terminated
NCT66521,Phase 2 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,Metformin,Phase 1,Terminated
NCT11351,Phase 1 Study of Metformin in Rheumatoid Arthritis,Asthma,IL-6 Inhibitor,Phase 3,Withdrawn
NCT81695,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Asthma,IL-6 Inhibitor,Phase 1,Withdrawn
NCT33948,Phase 3 Study of mRNA-101 in Alzheimer's,Alzheimer's,IL-6 Inhibitor,Phase 3,Completed
NCT22898,Phase 1 Study of BACE Inhibitor in Cancer,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Terminated
NCT16088,Phase 2 Study of Monoclonal Antibody in Cancer,Asthma,Monoclonal Antibody,Phase 3,Terminated
NCT78571,Phase 2 Study of BACE Inhibitor in Asthma,Asthma,mRNA-101,Phase 2,Terminated
NCT28907,Phase 3 Study of BACE Inhibitor in Asthma,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Terminated
NCT96850,Phase 3 Study of mRNA-101 in Asthma,Type 2 Diabetes,Metformin,Phase 2,Withdrawn
NCT85703,Phase 2 Study of mRNA-101 in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Completed
NCT12896,Phase 1 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Withdrawn
NCT40645,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Cancer,Monoclonal Antibody,Phase 1,Completed
NCT28298,Phase 1 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,Monoclonal Antibody,Phase 2,Withdrawn
NCT61993,Phase 2 Study of BACE Inhibitor in Type 2 Diabetes,Asthma,Monoclonal Antibody,Phase 1,Completed
NCT36994,Phase 1 Study of mRNA-101 in Asthma,Cancer,IL-6 Inhibitor,Phase 2,Completed
NCT66841,Phase 3 Study of IL-6 Inhibitor in Cancer,Asthma,Metformin,Phase 1,Terminated
NCT70409,Phase 2 Study of IL-6 Inhibitor in Cancer,Rheumatoid Arthritis,mRNA-101,Phase 1,Terminated
NCT87989,Phase 2 Study of BACE Inhibitor in Asthma,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Terminated
NCT84841,Phase 3 Study of IL-6 Inhibitor in Asthma,Asthma,Monoclonal Antibody,Phase 2,Recruiting
NCT84702,Phase 3 Study of Monoclonal Antibody in Alzheimer's,Asthma,mRNA-101,Phase 2,Withdrawn
NCT97318,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Type 2 Diabetes,Metformin,Phase 2,Completed
NCT70623,Phase 3 Study of Monoclonal Antibody in Asthma,Rheumatoid Arthritis,Metformin,Phase 2,Recruiting
NCT14417,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Asthma,Metformin,Phase 2,Recruiting
NCT50766,Phase 3 Study of Metformin in Asthma,Asthma,IL-6 Inhibitor,Phase 2,Withdrawn
NCT84695,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,IL-6 Inhibitor,Phase 1,Recruiting
NCT25492,Phase 1 Study of BACE Inhibitor in Cancer,Alzheimer's,Monoclonal Antibody,Phase 3,Terminated
NCT38135,Phase 1 Study of mRNA-101 in Asthma,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Withdrawn
NCT34627,Phase 1 Study of Metformin in Asthma,Asthma,IL-6 Inhibitor,Phase 3,Withdrawn
NCT66264,Phase 1 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,Metformin,Phase 2,Withdrawn
NCT83736,Phase 3 Study of Monoclonal Antibody in Asthma,Alzheimer's,Monoclonal Antibody,Phase 1,Terminated
NCT69161,Phase 2 Study of mRNA-101 in Asthma,Alzheimer's,Metformin,Phase 3,Completed
NCT48372,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Asthma,mRNA-101,Phase 3,Recruiting
NCT57563,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Alzheimer's,BACE Inhibitor,Phase 1,Terminated
NCT70688,Phase 1 Study of mRNA-101 in Alzheimer's,Type 2 Diabetes,Metformin,Phase 2,Terminated
NCT53338,Phase 3 Study of Metformin in Type 2 Diabetes,Cancer,Monoclonal Antibody,Phase 2,Recruiting
NCT67408,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Completed
NCT15446,Phase 2 Study of mRNA-101 in Cancer,Asthma,Metformin,Phase 3,Recruiting
NCT40991,Phase 2 Study of mRNA-101 in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 1,Recruiting
NCT48207,Phase 3 Study of BACE Inhibitor in Type 2 Diabetes,Alzheimer's,Monoclonal Antibody,Phase 2,Completed
NCT10333,Phase 2 Study of Monoclonal Antibody in Asthma,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Completed
NCT37233,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Asthma,Monoclonal Antibody,Phase 1,Recruiting
NCT73511,Phase 3 Study of Monoclonal Antibody in Alzheimer's,Type 2 Diabetes,Metformin,Phase 1,Completed
NCT19927,Phase 3 Study of Metformin in Alzheimer's,Cancer,Monoclonal Antibody,Phase 1,Completed
NCT93415,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,Monoclonal Antibody,Phase 1,Terminated
NCT18760,Phase 2 Study of BACE Inhibitor in Rheumatoid Arthritis,Asthma,IL-6 Inhibitor,Phase 3,Recruiting
NCT93236,Phase 3 Study of mRNA-101 in Asthma,Type 2 Diabetes,Metformin,Phase 3,Completed
NCT34804,Phase 2 Study of Metformin in Cancer,Asthma,Monoclonal Antibody,Phase 2,Completed
NCT27476,Phase 3 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Terminated
NCT59633,Phase 3 Study of Metformin in Asthma,Asthma,mRNA-101,Phase 3,Completed
NCT39762,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Alzheimer's,mRNA-101,Phase 1,Terminated
NCT97988,Phase 1 Study of IL-6 Inhibitor in Alzheimer's,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Completed
NCT60631,Phase 3 Study of mRNA-101 in Asthma,Asthma,mRNA-101,Phase 1,Withdrawn
NCT30381,Phase 1 Study of BACE Inhibitor in Rheumatoid Arthritis,Type 2 Diabetes,Metformin,Phase 2,Withdrawn
NCT99105,Phase 3 Study of Metformin in Asthma,Asthma,mRNA-101,Phase 1,Recruiting
NCT25553,Phase 1 Study of Monoclonal Antibody in Rheumatoid Arthritis,Cancer,IL-6 Inhibitor,Phase 1,Withdrawn
NCT89882,Phase 2 Study of BACE Inhibitor in Rheumatoid Arthritis,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Completed
NCT65978,Phase 2 Study of BACE Inhibitor in Alzheimer's,Type 2 Diabetes,Monoclonal Antibody,Phase 3,Terminated
NCT43892,Phase 1 Study of Metformin in Type 2 Diabetes,Asthma,BACE Inhibitor,Phase 2,Terminated
NCT31817,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 2,Recruiting
NCT53620,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Alzheimer's,mRNA-101,Phase 3,Completed
NCT94334,Phase 3 Study of IL-6 Inhibitor in Asthma,Asthma,Monoclonal Antibody,Phase 1,Terminated
NCT38509,Phase 1 Study of BACE Inhibitor in Asthma,Cancer,BACE Inhibitor,Phase 2,Terminated
NCT82205,Phase 1 Study of BACE Inhibitor in Alzheimer's,Alzheimer's,Metformin,Phase 1,Withdrawn
NCT27672,Phase 1 Study of IL-6 Inhibitor in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Recruiting
NCT32058,Phase 2 Study of mRNA-101 in Rheumatoid Arthritis,Cancer,Metformin,Phase 2,Recruiting
NCT92334,Phase 3 Study of IL-6 Inhibitor in Cancer,Alzheimer's,mRNA-101,Phase 1,Completed
NCT99360,Phase 3 Study of mRNA-101 in Rheumatoid Arthritis,Cancer,Monoclonal Antibody,Phase 2,Recruiting
NCT37249,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 2,Completed
NCT77615,Phase 1 Study of Metformin in Rheumatoid Arthritis,Asthma,mRNA-101,Phase 3,Withdrawn
NCT73347,Phase 1 Study of Monoclonal Antibody in Rheumatoid Arthritis,Asthma,BACE Inhibitor,Phase 1,Completed
NCT63118,Phase 3 Study of Metformin in Rheumatoid Arthritis,Cancer,IL-6 Inhibitor,Phase 2,Recruiting
NCT30597,Phase 3 Study of Metformin in Type 2 Diabetes,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Withdrawn
NCT51371,Phase 2 Study of Metformin in Type 2 Diabetes,Asthma,BACE Inhibitor,Phase 1,Recruiting
NCT25508,Phase 2 Study of IL-6 Inhibitor in Asthma,Asthma,mRNA-101,Phase 3,Withdrawn
NCT59236,Phase 2 Study of IL-6 Inhibitor in Cancer,Alzheimer's,mRNA-101,Phase 2,Recruiting
NCT59102,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Cancer,mRNA-101,Phase 1,Terminated
NCT76601,Phase 3 Study of mRNA-101 in Asthma,Asthma,Metformin,Phase 2,Completed
NCT10650,Phase 2 Study of Monoclonal Antibody in Cancer,Alzheimer's,Monoclonal Antibody,Phase 3,Recruiting
NCT82186,Phase 3 Study of Metformin in Rheumatoid Arthritis,Alzheimer's,Monoclonal Antibody,Phase 1,Recruiting
NCT48742,Phase 1 Study of Metformin in Asthma,Asthma,mRNA-101,Phase 2,Withdrawn
NCT75513,Phase 2 Study of Metformin in Cancer,Type 2 Diabetes,BACE Inhibitor,Phase 1,Recruiting
NCT49725,Phase 2 Study of mRNA-101 in Alzheimer's,Asthma,IL-6 Inhibitor,Phase 1,Terminated
NCT36318,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Asthma,mRNA-101,Phase 2,Terminated
NCT59513,Phase 1 Study of mRNA-101 in Alzheimer's,Rheumatoid Arthritis,mRNA-101,Phase 2,Completed
NCT72540,Phase 3 Study of BACE Inhibitor in Alzheimer's,Asthma,BACE Inhibitor,Phase 1,Terminated
NCT96298,Phase 1 Study of IL-6 Inhibitor in Cancer,Asthma,Monoclonal Antibody,Phase 3,Completed
NCT95896,Phase 3 Study of mRNA-101 in Alzheimer's,Cancer,mRNA-101,Phase 3,Completed
NCT74769,Phase 3 Study of IL-6 Inhibitor in Asthma,Asthma,IL-6 Inhibitor,Phase 3,Completed
NCT50499,Phase 1 Study of mRNA-101 in Type 2 Diabetes,Asthma,Metformin,Phase 1,Recruiting
NCT97530,Phase 1 Study of Monoclonal Antibody in Cancer,Rheumatoid Arthritis,Monoclonal Antibody,Phase 2,Terminated
NCT85573,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Rheumatoid Arthritis,mRNA-101,Phase 1,Terminated
NCT21741,Phase 2 Study of Monoclonal Antibody in Asthma,Asthma,BACE Inhibitor,Phase 2,Withdrawn
NCT16816,Phase 2 Study of BACE Inhibitor in Cancer,Asthma,mRNA-101,Phase 2,Recruiting
NCT89576,Phase 3 Study of Metformin in Alzheimer's,Alzheimer's,BACE Inhibitor,Phase 1,Withdrawn
NCT73345,Phase 1 Study of BACE Inhibitor in Type 2 Diabetes,Type 2 Diabetes,mRNA-101,Phase 3,Completed
NCT84103,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Completed
NCT64826,Phase 1 Study of Monoclonal Antibody in Rheumatoid Arthritis,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Recruiting
NCT77909,Phase 2 Study of BACE Inhibitor in Type 2 Diabetes,Asthma,Monoclonal Antibody,Phase 2,Withdrawn
NCT23349,Phase 2 Study of Metformin in Alzheimer's,Asthma,Metformin,Phase 3,Completed
NCT97921,Phase 3 Study of BACE Inhibitor in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Recruiting
NCT97949,Phase 1 Study of Monoclonal Antibody in Alzheimer's,Cancer,mRNA-101,Phase 1,Withdrawn
NCT98326,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,IL-6 Inhibitor,Phase 1,Terminated
NCT34570,Phase 2 Study of IL-6 Inhibitor in Asthma,Cancer,IL-6 Inhibitor,Phase 2,Recruiting
NCT98812,Phase 3 Study of BACE Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,mRNA-101,Phase 2,Withdrawn
NCT46694,Phase 1 Study of Monoclonal Antibody in Alzheimer's,Cancer,mRNA-101,Phase 3,Terminated
NCT93518,Phase 3 Study of Monoclonal Antibody in Asthma,Cancer,Monoclonal Antibody,Phase 2,Recruiting
NCT49485,Phase 1 Study of Metformin in Cancer,Alzheimer's,Monoclonal Antibody,Phase 1,Withdrawn
NCT44007,Phase 3 Study of Metformin in Type 2 Diabetes,Cancer,Metformin,Phase 1,Recruiting
NCT94008,Phase 1 Study of Metformin in Alzheimer's,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Completed
NCT41367,Phase 3 Study of Metformin in Alzheimer's,Alzheimer's,Monoclonal Antibody,Phase 1,Withdrawn
NCT53072,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Asthma,BACE Inhibitor,Phase 3,Recruiting
NCT55476,Phase 1 Study of Metformin in Asthma,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Terminated
NCT11199,Phase 1 Study of BACE Inhibitor in Type 2 Diabetes,Type 2 Diabetes,Metformin,Phase 2,Completed
NCT61893,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Completed
NCT54275,Phase 1 Study of Monoclonal Antibody in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 2,Completed
NCT18589,Phase 2 Study of Metformin in Type 2 Diabetes,Asthma,Metformin,Phase 2,Withdrawn
NCT23686,Phase 1 Study of IL-6 Inhibitor in Asthma,Cancer,mRNA-101,Phase 1,Recruiting
NCT88058,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 3,Terminated
NCT91999,Phase 1 Study of Monoclonal Antibody in Alzheimer's,Alzheimer's,mRNA-101,Phase 3,Withdrawn
NCT28419,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Type 2 Diabetes,Metformin,Phase 1,Withdrawn
NCT80117,Phase 1 Study of Metformin in Rheumatoid Arthritis,Alzheimer's,Monoclonal Antibody,Phase 3,Completed
NCT77472,Phase 1 Study of IL-6 Inhibitor in Cancer,Cancer,Metformin,Phase 3,Completed
NCT72962,Phase 3 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,mRNA-101,Phase 2,Terminated
NCT95438,Phase 2 Study of BACE Inhibitor in Cancer,Rheumatoid Arthritis,mRNA-101,Phase 3,Withdrawn
NCT49118,Phase 3 Study of BACE Inhibitor in Type 2 Diabetes,Asthma,mRNA-101,Phase 1,Completed
NCT59361,Phase 3 Study of BACE Inhibitor in Asthma,Alzheimer's,BACE Inhibitor,Phase 2,Completed
NCT91989,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,Monoclonal Antibody,Phase 3,Completed
NCT83760,Phase 3 Study of mRNA-101 in Rheumatoid Arthritis,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Completed
NCT40950,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Completed
NCT78466,Phase 2 Study of mRNA-101 in Cancer,Asthma,Metformin,Phase 2,Completed
NCT77565,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Terminated
NCT33224,Phase 1 Study of BACE Inhibitor in Type 2 Diabetes,Asthma,mRNA-101,Phase 2,Completed
NCT62099,Phase 2 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Terminated
NCT75133,Phase 3 Study of mRNA-101 in Alzheimer's,Alzheimer's,Metformin,Phase 2,Recruiting
NCT11110,Phase 1 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Recruiting
NCT42413,Phase 1 Study of mRNA-101 in Asthma,Asthma,IL-6 Inhibitor,Phase 2,Completed
NCT85295,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Alzheimer's,Metformin,Phase 2,Recruiting
NCT31642,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Alzheimer's,Monoclonal Antibody,Phase 1,Completed
NCT66042,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,BACE Inhibitor,Phase 1,Terminated
NCT32052,Phase 3 Study of Metformin in Rheumatoid Arthritis,Cancer,mRNA-101,Phase 3,Withdrawn
NCT55774,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Recruiting
NCT73570,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Alzheimer's,Metformin,Phase 1,Recruiting
NCT46410,Phase 2 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Terminated
NCT85432,Phase 3 Study of BACE Inhibitor in Cancer,Alzheimer's,BACE Inhibitor,Phase 3,Completed
NCT42383,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,Monoclonal Antibody,Phase 3,Withdrawn
NCT11891,Phase 3 Study of mRNA-101 in Cancer,Alzheimer's,mRNA-101,Phase 2,Terminated
NCT11515,Phase 1 Study of mRNA-101 in Asthma,Type 2 Diabetes,mRNA-101,Phase 1,Recruiting
NCT91582,Phase 2 Study of mRNA-101 in Asthma,Cancer,IL-6 Inhibitor,Phase 1,Recruiting
NCT11533,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Cancer,IL-6 Inhibitor,Phase 3,Terminated
NCT25826,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Alzheimer's,BACE Inhibitor,Phase 1,Recruiting
NCT25506,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Cancer,Metformin,Phase 1,Completed
NCT74107,Phase 2 Study of BACE Inhibitor in Cancer,Cancer,mRNA-101,Phase 3,Terminated
NCT48078,Phase 2 Study of BACE Inhibitor in Type 2 Diabetes,Asthma,Monoclonal Antibody,Phase 2,Terminated
NCT78670,Phase 3 Study of IL-6 Inhibitor in Asthma,Cancer,Metformin,Phase 3,Recruiting
NCT85462,Phase 1 Study of Monoclonal Antibody in Asthma,Cancer,BACE Inhibitor,Phase 1,Completed
NCT60606,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Asthma,Metformin,Phase 2,Withdrawn
NCT90813,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Cancer,IL-6 Inhibitor,Phase 2,Recruiting
NCT82372,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Alzheimer's,IL-6 Inhibitor,Phase 2,Terminated
NCT30700,Phase 1 Study of mRNA-101 in Alzheimer's,Asthma,IL-6 Inhibitor,Phase 2,Completed
NCT57374,Phase 2 Study of BACE Inhibitor in Alzheimer's,Cancer,mRNA-101,Phase 1,Terminated
NCT10330,Phase 2 Study of IL-6 Inhibitor in Cancer,Alzheimer's,IL-6 Inhibitor,Phase 1,Completed
NCT92384,Phase 3 Study of Monoclonal Antibody in Asthma,Alzheimer's,BACE Inhibitor,Phase 2,Completed
NCT91828,Phase 1 Study of BACE Inhibitor in Asthma,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Terminated
NCT14429,Phase 1 Study of IL-6 Inhibitor in Asthma,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Withdrawn
NCT92492,Phase 2 Study of Monoclonal Antibody in Cancer,Cancer,Metformin,Phase 2,Terminated
NCT57407,Phase 3 Study of mRNA-101 in Alzheimer's,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Withdrawn
NCT90713,Phase 1 Study of mRNA-101 in Alzheimer's,Rheumatoid Arthritis,Metformin,Phase 2,Recruiting
NCT20448,Phase 3 Study of BACE Inhibitor in Type 2 Diabetes,Asthma,IL-6 Inhibitor,Phase 1,Completed
NCT28300,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Cancer,Metformin,Phase 2,Terminated
NCT79409,Phase 3 Study of BACE Inhibitor in Asthma,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Terminated
NCT26379,Phase 2 Study of BACE Inhibitor in Cancer,Alzheimer's,BACE Inhibitor,Phase 1,Withdrawn
NCT69853,Phase 3 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Completed
NCT26139,Phase 3 Study of mRNA-101 in Alzheimer's,Cancer,Metformin,Phase 2,Withdrawn
NCT92588,Phase 2 Study of Metformin in Asthma,Type 2 Diabetes,Metformin,Phase 3,Terminated
NCT83445,Phase 3 Study of Metformin in Cancer,Alzheimer's,IL-6 Inhibitor,Phase 1,Recruiting
NCT50360,Phase 3 Study of Monoclonal Antibody in Alzheimer's,Cancer,Metformin,Phase 3,Completed
NCT51242,Phase 3 Study of mRNA-101 in Rheumatoid Arthritis,Alzheimer's,mRNA-101,Phase 2,Completed
NCT88918,Phase 3 Study of IL-6 Inhibitor in Cancer,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Terminated
NCT22601,Phase 1 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Alzheimer's,mRNA-101,Phase 1,Terminated
NCT16321,Phase 2 Study of BACE Inhibitor in Rheumatoid Arthritis,Asthma,mRNA-101,Phase 1,Terminated
NCT37772,Phase 1 Study of Monoclonal Antibody in Cancer,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 2,Recruiting
NCT28948,Phase 3 Study of mRNA-101 in Asthma,Alzheimer's,IL-6 Inhibitor,Phase 1,Completed
NCT12094,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 3,Recruiting
NCT24534,Phase 2 Study of BACE Inhibitor in Cancer,Asthma,Monoclonal Antibody,Phase 2,Completed
NCT17795,Phase 3 Study of mRNA-101 in Asthma,Asthma,mRNA-101,Phase 1,Terminated
NCT75940,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,BACE Inhibitor,Phase 1,Withdrawn
NCT88415,Phase 2 Study of Metformin in Alzheimer's,Alzheimer's,mRNA-101,Phase 2,Terminated
NCT49922,Phase 2 Study of Metformin in Alzheimer's,Type 2 Diabetes,BACE Inhibitor,Phase 2,Recruiting
NCT52235,Phase 1 Study of BACE Inhibitor in Asthma,Asthma,Metformin,Phase 1,Recruiting
NCT63250,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Type 2 Diabetes,mRNA-101,Phase 2,Recruiting
NCT29298,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,mRNA-101,Phase 1,Terminated
NCT55494,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 2,Completed
NCT49677,Phase 2 Study of IL-6 Inhibitor in Asthma,Alzheimer's,BACE Inhibitor,Phase 1,Recruiting
NCT90599,Phase 1 Study of Metformin in Cancer,Alzheimer's,Metformin,Phase 1,Terminated
NCT14032,Phase 2 Study of Monoclonal Antibody in Asthma,Alzheimer's,Monoclonal Antibody,Phase 3,Completed
NCT50753,Phase 1 Study of BACE Inhibitor in Asthma,Asthma,mRNA-101,Phase 2,Completed
NCT26666,Phase 1 Study of mRNA-101 in Alzheimer's,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Terminated
NCT77563,Phase 3 Study of Metformin in Type 2 Diabetes,Asthma,BACE Inhibitor,Phase 3,Withdrawn
NCT15420,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Alzheimer's,Metformin,Phase 2,Recruiting
NCT43174,Phase 3 Study of mRNA-101 in Alzheimer's,Alzheimer's,mRNA-101,Phase 1,Recruiting
NCT44195,Phase 1 Study of BACE Inhibitor in Asthma,Type 2 Diabetes,Monoclonal Antibody,Phase 3,Withdrawn
NCT17256,Phase 3 Study of IL-6 Inhibitor in Asthma,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Withdrawn
NCT45780,Phase 3 Study of Metformin in Type 2 Diabetes,Type 2 Diabetes,BACE Inhibitor,Phase 1,Recruiting
NCT56848,Phase 2 Study of IL-6 Inhibitor in Asthma,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Completed
NCT86086,Phase 3 Study of IL-6 Inhibitor in Asthma,Asthma,BACE Inhibitor,Phase 3,Terminated
NCT41837,Phase 1 Study of mRNA-101 in Asthma,Type 2 Diabetes,BACE Inhibitor,Phase 2,Recruiting
NCT66826,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Asthma,BACE Inhibitor,Phase 1,Recruiting
NCT24546,Phase 2 Study of mRNA-101 in Asthma,Type 2 Diabetes,BACE Inhibitor,Phase 3,Withdrawn
NCT41964,Phase 1 Study of IL-6 Inhibitor in Cancer,Type 2 Diabetes,Monoclonal Antibody,Phase 3,Withdrawn
NCT89249,Phase 2 Study of IL-6 Inhibitor in Asthma,Rheumatoid Arthritis,mRNA-101,Phase 2,Recruiting
NCT51389,Phase 3 Study of Metformin in Type 2 Diabetes,Asthma,mRNA-101,Phase 1,Withdrawn
NCT45816,Phase 3 Study of Monoclonal Antibody in Asthma,Type 2 Diabetes,BACE Inhibitor,Phase 3,Withdrawn
NCT77549,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 3,Recruiting
NCT12473,Phase 1 Study of BACE Inhibitor in Cancer,Asthma,BACE Inhibitor,Phase 3,Withdrawn
NCT87362,Phase 1 Study of Monoclonal Antibody in Alzheimer's,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Withdrawn
NCT87855,Phase 2 Study of Monoclonal Antibody in Asthma,Alzheimer's,IL-6 Inhibitor,Phase 2,Completed
NCT32957,Phase 3 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,Metformin,Phase 2,Withdrawn
NCT13524,Phase 3 Study of Metformin in Rheumatoid Arthritis,Type 2 Diabetes,IL-6 Inhibitor,Phase 2,Recruiting
NCT32356,Phase 2 Study of mRNA-101 in Cancer,Alzheimer's,Metformin,Phase 3,Terminated
NCT60284,Phase 1 Study of Metformin in Cancer,Asthma,BACE Inhibitor,Phase 1,Terminated
NCT38612,Phase 1 Study of Metformin in Alzheimer's,Asthma,BACE Inhibitor,Phase 2,Recruiting
NCT65596,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,Metformin,Phase 1,Recruiting
NCT25209,Phase 3 Study of BACE Inhibitor in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 1,Terminated
NCT19769,Phase 1 Study of Metformin in Cancer,Asthma,mRNA-101,Phase 3,Recruiting
NCT89508,Phase 1 Study of IL-6 Inhibitor in Alzheimer's,Alzheimer's,mRNA-101,Phase 3,Terminated
NCT92525,Phase 1 Study of BACE Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Withdrawn
NCT81402,Phase 1 Study of Metformin in Alzheimer's,Asthma,Metformin,Phase 2,Terminated
NCT75371,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Cancer,IL-6 Inhibitor,Phase 3,Completed
NCT40317,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Terminated
NCT29829,Phase 1 Study of mRNA-101 in Asthma,Cancer,Metformin,Phase 1,Terminated
NCT85993,Phase 3 Study of Metformin in Rheumatoid Arthritis,Alzheimer's,Metformin,Phase 3,Recruiting
NCT79717,Phase 2 Study of BACE Inhibitor in Type 2 Diabetes,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Withdrawn
NCT80899,Phase 3 Study of Metformin in Type 2 Diabetes,Asthma,Monoclonal Antibody,Phase 2,Recruiting
NCT70428,Phase 2 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Recruiting
NCT76214,Phase 1 Study of BACE Inhibitor in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 3,Recruiting
NCT60238,Phase 1 Study of Metformin in Asthma,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Terminated
NCT28120,Phase 2 Study of mRNA-101 in Asthma,Cancer,IL-6 Inhibitor,Phase 1,Withdrawn
NCT97428,Phase 2 Study of Metformin in Asthma,Alzheimer's,IL-6 Inhibitor,Phase 3,Terminated
NCT89945,Phase 1 Study of Monoclonal Antibody in Asthma,Cancer,BACE Inhibitor,Phase 2,Withdrawn
NCT55488,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 1,Terminated
NCT77725,Phase 1 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,Metformin,Phase 2,Withdrawn
NCT60900,Phase 2 Study of mRNA-101 in Asthma,Alzheimer's,IL-6 Inhibitor,Phase 3,Terminated
NCT64781,Phase 1 Study of Monoclonal Antibody in Cancer,Asthma,Metformin,Phase 3,Recruiting
NCT18722,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Cancer,Metformin,Phase 3,Completed
NCT13035,Phase 3 Study of BACE Inhibitor in Alzheimer's,Asthma,BACE Inhibitor,Phase 1,Recruiting
NCT81421,Phase 2 Study of Metformin in Asthma,Cancer,mRNA-101,Phase 2,Completed
NCT66541,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Alzheimer's,mRNA-101,Phase 1,Withdrawn
NCT14545,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Completed
NCT11327,Phase 3 Study of Metformin in Cancer,Asthma,Monoclonal Antibody,Phase 2,Withdrawn
NCT41221,Phase 1 Study of mRNA-101 in Alzheimer's,Cancer,mRNA-101,Phase 3,Withdrawn
NCT90830,Phase 3 Study of Metformin in Asthma,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Withdrawn
NCT60376,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Asthma,BACE Inhibitor,Phase 1,Terminated
NCT45205,Phase 2 Study of Monoclonal Antibody in Cancer,Cancer,Monoclonal Antibody,Phase 2,Completed
NCT98554,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Type 2 Diabetes,mRNA-101,Phase 2,Completed
NCT83326,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 1,Recruiting
NCT34102,Phase 3 Study of mRNA-101 in Rheumatoid Arthritis,Cancer,Monoclonal Antibody,Phase 3,Recruiting
NCT46265,Phase 1 Study of mRNA-101 in Alzheimer's,Type 2 Diabetes,Monoclonal Antibody,Phase 3,Withdrawn
NCT83821,Phase 2 Study of BACE Inhibitor in Cancer,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Withdrawn
NCT21525,Phase 3 Study of mRNA-101 in Type 2 Diabetes,Asthma,Metformin,Phase 1,Terminated
NCT57256,Phase 2 Study of BACE Inhibitor in Cancer,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Terminated
NCT56370,Phase 1 Study of mRNA-101 in Asthma,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Recruiting
NCT30399,Phase 1 Study of Metformin in Type 2 Diabetes,Rheumatoid Arthritis,mRNA-101,Phase 1,Recruiting
NCT19020,Phase 3 Study of IL-6 Inhibitor in Alzheimer's,Alzheimer's,BACE Inhibitor,Phase 2,Completed
NCT13709,Phase 2 Study of Metformin in Cancer,Asthma,IL-6 Inhibitor,Phase 3,Completed
NCT30834,Phase 3 Study of BACE Inhibitor in Asthma,Cancer,BACE Inhibitor,Phase 2,Recruiting
NCT57186,Phase 2 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,BACE Inhibitor,Phase 3,Recruiting
NCT43346,Phase 2 Study of BACE Inhibitor in Rheumatoid Arthritis,Cancer,Metformin,Phase 2,Withdrawn
NCT95409,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,Metformin,Phase 3,Recruiting
NCT94384,Phase 1 Study of mRNA-101 in Alzheimer's,Rheumatoid Arthritis,Metformin,Phase 1,Recruiting
NCT85112,Phase 2 Study of Metformin in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Recruiting
NCT81262,Phase 3 Study of Metformin in Asthma,Alzheimer's,BACE Inhibitor,Phase 3,Withdrawn
NCT31279,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Recruiting
NCT45952,Phase 1 Study of Metformin in Type 2 Diabetes,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Terminated
NCT23998,Phase 2 Study of Metformin in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Withdrawn
NCT46880,Phase 3 Study of IL-6 Inhibitor in Asthma,Rheumatoid Arthritis,Metformin,Phase 3,Withdrawn
NCT77761,Phase 1 Study of IL-6 Inhibitor in Asthma,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Completed
NCT35404,Phase 1 Study of BACE Inhibitor in Type 2 Diabetes,Type 2 Diabetes,mRNA-101,Phase 1,Terminated
NCT63801,Phase 2 Study of BACE Inhibitor in Rheumatoid Arthritis,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Completed
NCT91044,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Recruiting
NCT75295,Phase 1 Study of IL-6 Inhibitor in Cancer,Cancer,IL-6 Inhibitor,Phase 1,Completed
NCT40242,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Alzheimer's,BACE Inhibitor,Phase 3,Withdrawn
NCT26012,Phase 3 Study of Metformin in Alzheimer's,Type 2 Diabetes,BACE Inhibitor,Phase 3,Recruiting
NCT38052,Phase 3 Study of BACE Inhibitor in Type 2 Diabetes,Type 2 Diabetes,Metformin,Phase 1,Terminated
NCT53830,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Alzheimer's,mRNA-101,Phase 3,Withdrawn
NCT33964,Phase 2 Study of Metformin in Asthma,Type 2 Diabetes,IL-6 Inhibitor,Phase 1,Terminated
NCT97789,Phase 1 Study of Metformin in Type 2 Diabetes,Cancer,mRNA-101,Phase 3,Withdrawn
NCT91341,Phase 2 Study of BACE Inhibitor in Type 2 Diabetes,Asthma,Metformin,Phase 3,Recruiting
NCT57177,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,BACE Inhibitor,Phase 1,Recruiting
NCT20931,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Alzheimer's,Metformin,Phase 3,Recruiting
NCT12871,Phase 2 Study of mRNA-101 in Asthma,Alzheimer's,Metformin,Phase 1,Recruiting
NCT85808,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Terminated
NCT64177,Phase 1 Study of BACE Inhibitor in Alzheimer's,Cancer,Metformin,Phase 1,Completed
NCT42753,Phase 2 Study of mRNA-101 in Cancer,Alzheimer's,BACE Inhibitor,Phase 1,Completed
NCT11653,Phase 2 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Asthma,mRNA-101,Phase 1,Terminated
NCT42685,Phase 3 Study of Metformin in Alzheimer's,Asthma,Monoclonal Antibody,Phase 2,Withdrawn
NCT56619,Phase 1 Study of mRNA-101 in Alzheimer's,Alzheimer's,IL-6 Inhibitor,Phase 1,Terminated
NCT26472,Phase 1 Study of Metformin in Alzheimer's,Type 2 Diabetes,IL-6 Inhibitor,Phase 3,Completed
NCT98420,Phase 3 Study of IL-6 Inhibitor in Asthma,Cancer,IL-6 Inhibitor,Phase 2,Withdrawn
NCT22740,Phase 1 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,Metformin,Phase 2,Terminated
NCT14147,Phase 3 Study of Monoclonal Antibody in Asthma,Alzheimer's,Metformin,Phase 2,Terminated
NCT86835,Phase 1 Study of Metformin in Type 2 Diabetes,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Withdrawn
NCT66941,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Cancer,BACE Inhibitor,Phase 1,Terminated
NCT98665,Phase 1 Study of BACE Inhibitor in Alzheimer's,Cancer,BACE Inhibitor,Phase 3,Withdrawn
NCT44961,Phase 3 Study of Metformin in Alzheimer's,Cancer,BACE Inhibitor,Phase 1,Completed
NCT91867,Phase 2 Study of mRNA-101 in Alzheimer's,Rheumatoid Arthritis,BACE Inhibitor,Phase 2,Completed
NCT83383,Phase 3 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Recruiting
NCT46073,Phase 3 Study of Metformin in Asthma,Rheumatoid Arthritis,Metformin,Phase 1,Terminated
NCT97906,Phase 1 Study of Metformin in Rheumatoid Arthritis,Asthma,Monoclonal Antibody,Phase 1,Recruiting
NCT22444,Phase 1 Study of IL-6 Inhibitor in Rheumatoid Arthritis,Cancer,mRNA-101,Phase 3,Withdrawn
NCT19421,Phase 2 Study of Monoclonal Antibody in Type 2 Diabetes,Rheumatoid Arthritis,mRNA-101,Phase 3,Recruiting
NCT10581,Phase 1 Study of IL-6 Inhibitor in Cancer,Asthma,mRNA-101,Phase 2,Withdrawn
NCT15353,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Recruiting
NCT71409,Phase 2 Study of mRNA-101 in Alzheimer's,Type 2 Diabetes,BACE Inhibitor,Phase 3,Completed
NCT88434,Phase 1 Study of BACE Inhibitor in Cancer,Rheumatoid Arthritis,Monoclonal Antibody,Phase 3,Recruiting
NCT89032,Phase 3 Study of BACE Inhibitor in Asthma,Type 2 Diabetes,Metformin,Phase 3,Terminated
NCT94658,Phase 2 Study of IL-6 Inhibitor in Type 2 Diabetes,Alzheimer's,IL-6 Inhibitor,Phase 1,Completed
NCT69899,Phase 1 Study of Monoclonal Antibody in Rheumatoid Arthritis,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 3,Completed
NCT83521,Phase 1 Study of BACE Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Terminated
NCT49888,Phase 3 Study of Monoclonal Antibody in Type 2 Diabetes,Alzheimer's,Metformin,Phase 2,Recruiting
NCT39999,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Rheumatoid Arthritis,Monoclonal Antibody,Phase 1,Withdrawn
NCT83929,Phase 3 Study of IL-6 Inhibitor in Type 2 Diabetes,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Completed
NCT90553,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Asthma,IL-6 Inhibitor,Phase 1,Completed
NCT10599,Phase 1 Study of Metformin in Alzheimer's,Alzheimer's,BACE Inhibitor,Phase 1,Completed
NCT94648,Phase 1 Study of IL-6 Inhibitor in Type 2 Diabetes,Alzheimer's,Metformin,Phase 2,Withdrawn
NCT96059,Phase 3 Study of mRNA-101 in Cancer,Alzheimer's,Monoclonal Antibody,Phase 1,Completed
NCT62482,Phase 3 Study of IL-6 Inhibitor in Cancer,Alzheimer's,Metformin,Phase 3,Completed
NCT94868,Phase 3 Study of Monoclonal Antibody in Cancer,Cancer,Metformin,Phase 1,Recruiting
NCT74675,Phase 1 Study of mRNA-101 in Rheumatoid Arthritis,Asthma,IL-6 Inhibitor,Phase 3,Completed
NCT56096,Phase 3 Study of BACE Inhibitor in Alzheimer's,Asthma,IL-6 Inhibitor,Phase 3,Recruiting
NCT55982,Phase 2 Study of Monoclonal Antibody in Alzheimer's,Alzheimer's,mRNA-101,Phase 1,Withdrawn
NCT67553,Phase 2 Study of Metformin in Rheumatoid Arthritis,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 1,Terminated
NCT83124,Phase 3 Study of BACE Inhibitor in Asthma,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Terminated
NCT57408,Phase 1 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,Metformin,Phase 1,Withdrawn
NCT80589,Phase 2 Study of IL-6 Inhibitor in Asthma,Cancer,Monoclonal Antibody,Phase 2,Withdrawn
NCT86981,Phase 1 Study of Monoclonal Antibody in Cancer,Type 2 Diabetes,Metformin,Phase 1,Recruiting
NCT90864,Phase 3 Study of mRNA-101 in Cancer,Rheumatoid Arthritis,IL-6 Inhibitor,Phase 2,Withdrawn
NCT14836,Phase 1 Study of Monoclonal Antibody in Cancer,Rheumatoid Arthritis,Metformin,Phase 2,Recruiting
NCT31792,Phase 3 Study of Metformin in Type 2 Diabetes,Cancer,BACE Inhibitor,Phase 2,Recruiting
NCT36362,Phase 2 Study of mRNA-101 in Type 2 Diabetes,Alzheimer's,BACE Inhibitor,Phase 3,Withdrawn
NCT87426,Phase 2 Study of IL-6 Inhibitor in Alzheimer's,Type 2 Diabetes,Monoclonal Antibody,Phase 2,Withdrawn
NCT27622,Phase 2 Study of Metformin in Asthma,Alzheimer's,IL-6 Inhibitor,Phase 1,Terminated
NCT32578,Phase 3 Study of IL-6 Inhibitor in Asthma,Cancer,BACE Inhibitor,Phase 3,Completed
NCT69614,Phase 1 Study of mRNA-101 in Alzheimer's,Asthma,IL-6 Inhibitor,Phase 3,Completed
NCT63511,Phase 1 Study of BACE Inhibitor in Type 2 Diabetes,Asthma,mRNA-101,Phase 3,Terminated
NCT69944,Phase 1 Study of Monoclonal Antibody in Type 2 Diabetes,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Terminated
NCT49514,Phase 3 Study of BACE Inhibitor in Rheumatoid Arthritis,Type 2 Diabetes,Monoclonal Antibody,Phase 1,Withdrawn
NCT11140,Phase 3 Study of BACE Inhibitor in Type 2 Diabetes,Alzheimer's,mRNA-101,Phase 2,Withdrawn
NCT96233,Phase 3 Study of BACE Inhibitor in Cancer,Rheumatoid Arthritis,BACE Inhibitor,Phase 1,Terminated
NCT91015,Phase 2 Study of Monoclonal Antibody in Rheumatoid Arthritis,Cancer,mRNA-101,Phase 1,Recruiting
